data_2ll2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ll2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 122.314 1.054 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.785 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -69.0 0.8 12.68 Favored Glycine 0 C--N 1.299 -1.488 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.723 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 8' ' ' LYS . 5.8 mmmm 46.94 -2.74 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.641 0.734 . . . . 0.0 112.937 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.785 ' H ' ' C ' ' A' ' 9' ' ' GLY . 39.0 t -93.94 -1.94 53.95 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.459 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.916 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.8 t70 -46.83 109.81 1.13 Allowed Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.924 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.928 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 34.1 Cg_endo -71.0 -33.13 12.33 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 123.586 2.857 . . . . 0.0 116.674 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.928 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.21 -46.13 71.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.615 -178.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.47 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.8 m170 -74.72 -26.0 59.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 108.649 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.916 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -64.07 -30.56 71.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.605 -2.088 . . . . 0.0 110.962 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.528 HG21 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.99 -41.72 20.34 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.832 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 22' ' ' SER . 87.7 p -74.32 -18.44 60.7 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 112.018 -2.355 . . . . 0.0 110.226 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -77.28 -59.16 3.17 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.435 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.78 -24.0 55.03 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 23' ' ' PRO . 88.4 mt -102.26 7.44 40.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.637 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 57.2 m 16.52 -74.04 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.819 1.248 . . . . 0.0 114.313 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.637 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 15.8 Cg_endo -54.48 -15.28 8.46 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 C-N-CA 121.69 1.594 . . . . 0.0 112.31 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' SER . . . . . . . . 0 C--N 1.294 -1.844 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.014 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.494 -1.176 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -70.75 4.52 9.49 Favored Glycine 0 C--N 1.308 -1.01 0 CA-C-N 111.581 -2.554 . . . . 0.0 111.1 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 37.8 5.61 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 9' ' ' GLY . 45.5 t -94.93 -3.81 47.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.784 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.892 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 7.8 t70 -46.75 109.45 1.04 Allowed Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.931 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 37.3 Cg_endo -71.59 -33.48 10.56 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.576 2.85 . . . . 0.0 116.755 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.931 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -66.41 -47.06 74.45 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.045 -177.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.574 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 43.8 m170 -75.08 -25.81 58.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.502 1.144 . . . . 0.0 108.78 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.06 -30.54 71.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.019 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -84.16 -41.08 17.41 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.723 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.574 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 90.3 p -73.52 -18.7 61.06 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.193 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.09 -59.71 3.56 Favored Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.2 -24.95 57.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 23' ' ' PRO . 88.4 mt -101.31 7.21 42.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.488 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.644 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 51.3 m 16.1 -74.47 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.682 1.193 . . . . 0.0 114.135 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.644 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.3 Cg_endo -54.88 -13.35 6.06 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.862 1.708 . . . . 0.0 112.54 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.792 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.081 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.495 -1.14 0 CA-C-O 122.844 1.307 . . . . 0.0 107.766 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.83 2.99 7.11 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.213 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 36.07 8.26 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.742 ' N ' ' O ' ' A' ' 9' ' ' GLY . 44.3 t -95.03 -8.78 35.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.186 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.88 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 11.8 t70 -47.1 108.09 0.82 Allowed Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.945 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 56.3 Cg_endo -73.51 -34.08 6.15 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 123.733 2.955 . . . . 0.0 117.368 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.945 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.97 -46.71 70.6 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 51.6 m170 -74.94 -25.71 59.08 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.462 1.125 . . . . 0.0 108.669 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 12' ' ' ASP . . . -61.81 -32.38 72.67 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.715 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.0 -41.63 22.43 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.584 -178.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.54 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 91.9 p -70.09 -20.34 63.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.137 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -74.28 -59.37 3.92 Favored Glycine 0 CA--C 1.506 -0.502 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.328 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.6 -24.03 54.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' PRO . 89.7 mt -101.52 7.33 42.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.425 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.654 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 45.1 m 16.34 -74.45 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.585 1.154 . . . . 0.0 113.989 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.654 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 22.3 Cg_endo -56.51 -9.98 4.45 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 121.857 1.705 . . . . 0.0 112.59 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.81 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.648 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 7.6 mmmm . . . . . 0 CA--C 1.483 -1.609 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.19 0.83 10.21 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 110.392 -3.095 . . . . 0.0 111.074 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 38.17 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 9' ' ' GLY . 46.4 t -94.52 -9.7 34.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.508 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.906 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.1 t70 -46.93 109.85 1.14 Allowed Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.868 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.932 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 33.2 Cg_endo -71.0 -32.85 12.75 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 123.558 2.839 . . . . 0.0 116.813 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.932 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.54 -46.68 68.88 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.028 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.58 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.3 m170 -74.9 -25.78 59.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.565 1.174 . . . . 0.0 108.602 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.906 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.82 -31.82 72.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.646 -2.07 . . . . 0.0 110.654 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.523 HG21 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.89 -41.61 20.69 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.478 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -69.26 -20.37 63.93 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.893 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.22 -58.22 4.78 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.145 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.83 59.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 23' ' ' PRO . 89.9 mt -100.25 7.19 44.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.349 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.645 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 49.8 m 15.35 -73.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.702 1.201 . . . . 0.0 114.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.645 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.7 Cg_endo -54.88 -13.74 6.75 Favored 'Trans proline' 0 CA--C 1.508 -0.793 0 C-N-CA 121.787 1.658 . . . . 0.0 112.385 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.847 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.87 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.654 0 CA-C-O 121.574 0.702 . . . . 0.0 111.948 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.786 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -75.55 8.3 20.67 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.418 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 8' ' ' LYS . 20.3 mmmt 46.6 -4.88 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.786 ' H ' ' C ' ' A' ' 9' ' ' GLY . 35.8 t -94.66 -1.04 53.86 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.491 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.954 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 7.2 t70 -46.4 111.53 1.52 Allowed Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.27 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.862 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 24.1 Cg_endo -69.06 -30.56 25.34 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 123.732 2.955 . . . . 0.0 116.693 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.862 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -73.06 -46.11 53.54 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.35 -178.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.541 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 61.0 m170 -74.46 -25.58 59.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.495 1.141 . . . . 0.0 108.365 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.954 ' HB1' ' O ' ' A' ' 12' ' ' ASP . . . -61.97 -32.42 72.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.577 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -79.96 -41.93 24.99 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.559 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 82.5 p -70.98 -19.52 62.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.175 -2.284 . . . . 0.0 109.975 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.11 -57.51 4.34 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -24.6 58.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 23' ' ' PRO . 91.3 mt -100.3 7.27 44.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.382 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.664 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 44.8 m 15.89 -74.32 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.59 1.156 . . . . 0.0 113.814 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.664 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 20.3 Cg_endo -55.77 -9.76 3.23 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 121.957 1.771 . . . . 0.0 112.553 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 22' ' ' SER . . . . . . . . 0 C--N 1.294 -1.806 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.431 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.515 ' O ' ' HD2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.286 0 CA-C-O 122.933 1.349 . . . . 0.0 107.366 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.744 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -67.69 1.86 7.0 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 111.546 -2.57 . . . . 0.0 111.252 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 37.3 8.32 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.744 ' N ' ' O ' ' A' ' 9' ' ' GLY . 47.0 t -94.59 -6.02 44.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.37 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.9 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 13.2 t70 -46.81 109.3 1.01 Allowed Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.205 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.937 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 46.9 Cg_endo -72.1 -33.56 9.35 Favored 'Trans proline' 0 C--N 1.327 -0.564 0 C-N-CA 123.614 2.876 . . . . 0.0 116.622 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.937 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.29 -46.42 73.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.787 -177.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.524 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 55.8 m170 -74.92 -25.8 59.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.517 1.151 . . . . 0.0 108.765 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.9 ' HB1' ' O ' ' A' ' 12' ' ' ASP . . . -63.37 -30.82 71.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.025 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.534 HG21 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 -41.8 18.67 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.66 -1.609 . . . . 0.0 108.694 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 22' ' ' SER . 85.7 p -73.89 -17.27 61.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.157 -2.292 . . . . 0.0 110.054 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.84 -63.07 2.96 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.33 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.43 -24.97 58.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.609 ' O ' ' N ' ' A' ' 24' ' ' ALA . 93.9 mt -97.63 8.23 45.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.496 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.813 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.1 m 5.59 -64.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 48.6 Cg_exo -59.6 -9.72 9.8 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 121.541 1.494 . . . . 0.0 111.772 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 111.976 -2.374 . . . . 0.0 111.15 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.929 0 CA-C-O 122.215 1.007 . . . . 0.0 110.685 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.784 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -68.29 2.56 7.04 Favored Glycine 0 C--N 1.3 -1.446 0 CA-C-N 113.23 -1.805 . . . . 0.0 110.816 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 4.2 mmtt 45.78 -2.54 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 113.057 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.784 ' H ' ' C ' ' A' ' 9' ' ' GLY . 69.2 m -94.02 -1.35 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.473 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.922 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.2 t70 -46.89 110.47 1.28 Allowed Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.805 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.914 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 20.3 Cg_endo -69.64 -32.72 18.5 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 123.516 2.811 . . . . 0.0 116.526 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.914 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.22 -46.39 67.51 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.626 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 19' ' ' GLY . 57.8 m170 -74.76 -25.74 59.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.447 1.118 . . . . 0.0 108.624 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.922 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.47 -30.59 71.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.087 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.97 -41.77 18.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.741 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' SER . 88.0 p -74.96 -17.0 60.62 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 112.232 -2.258 . . . . 0.0 110.237 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.98 -62.84 2.85 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.434 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.82 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 24' ' ' ALA . 92.3 mt -98.79 8.19 45.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.6 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.833 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 7.16 -65.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.833 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 49.2 Cg_exo -59.55 -9.53 9.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.589 1.526 . . . . 0.0 111.745 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.04 0 CA-C-N 112.006 -2.361 . . . . 0.0 111.112 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.533 ' HE3' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.902 0 CA-C-O 122.741 1.258 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -76.36 4.17 50.32 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.784 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.438 ' CD ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 39.5 7.52 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 9' ' ' GLY . 68.8 m -94.59 -3.19 50.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.992 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.931 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.3 t70 -46.41 111.26 1.43 Allowed Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.409 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.876 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -69.17 -32.62 20.64 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 C-N-CA 123.555 2.836 . . . . 0.0 116.518 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.876 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.77 -46.2 66.34 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.52 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.519 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 58.0 m170 -74.64 -26.33 59.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.551 1.167 . . . . 0.0 108.463 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 12' ' ' ASP . . . -62.07 -31.81 72.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.806 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -80.72 -42.02 22.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.595 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -72.04 -18.09 61.98 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.065 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.75 -62.5 3.18 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.373 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.29 56.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 24' ' ' ALA . 95.2 mt -98.08 8.23 45.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.455 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.819 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.7 m 5.45 -64.26 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.819 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 51.1 Cg_exo -59.14 -9.74 8.82 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 121.672 1.581 . . . . 0.0 111.703 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.046 0 CA-C-N 111.955 -2.384 . . . . 0.0 111.279 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.558 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.757 0 CA-C-O 121.803 0.811 . . . . 0.0 111.874 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.778 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -74.64 9.04 11.58 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.548 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' CD ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 39.45 3.01 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.778 ' H ' ' C ' ' A' ' 9' ' ' GLY . 41.2 t -95.5 -3.03 47.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.35 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.9 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 8.0 t70 -46.35 109.48 1.01 Allowed Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.268 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.942 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 44.2 Cg_endo -72.12 -34.01 8.75 Favored 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 123.597 2.865 . . . . 0.0 116.774 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.942 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -65.42 -46.72 78.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.481 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.641 ' O ' ' N ' ' A' ' 19' ' ' GLY . 57.5 m170 -75.4 -25.2 57.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.398 1.094 . . . . 0.0 109.307 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.9 ' HB1' ' O ' ' A' ' 12' ' ' ASP . . . -66.55 -27.77 68.0 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.805 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -88.94 -40.88 12.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.971 -178.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 22' ' ' SER . 77.2 p -82.04 -13.57 57.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.345 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -76.44 -62.9 2.46 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.193 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.17 60.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.59 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.5 mt -96.88 8.15 45.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.586 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.871 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 8.88 -66.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 45.9 Cg_exo -60.14 -8.47 8.28 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 122.004 1.803 . . . . 0.0 111.938 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.059 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.725 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.592 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.93 0 CA-C-O 122.254 1.026 . . . . 0.0 110.898 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.78 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -70.88 5.17 8.17 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.898 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 40.02 3.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.78 ' H ' ' C ' ' A' ' 9' ' ' GLY . 40.0 t -95.16 -0.88 52.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.892 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 6.3 t70 -46.17 109.54 1.01 Allowed Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.783 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.953 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 28.6 Cg_endo -70.61 -33.16 13.81 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 123.394 2.729 . . . . 0.0 116.54 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.953 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -64.89 -46.62 80.98 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.555 -178.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.668 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.4 m170 -74.9 -25.76 59.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.578 1.18 . . . . 0.0 109.343 176.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.892 ' HB1' ' O ' ' A' ' 12' ' ' ASP . . . -69.17 -28.55 66.51 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.608 -2.087 . . . . 0.0 111.483 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 13' ' ' PRO . 1.2 m -98.35 -20.67 17.04 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.521 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.668 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -96.65 -15.87 21.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.686 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.15 -62.43 2.76 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.268 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 -25.07 58.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.612 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 79.6 mt -98.91 8.18 45.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.551 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.816 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.4 m 8.26 -65.76 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 43.0 Cg_exo -60.26 -9.24 10.07 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 121.53 1.487 . . . . 0.0 111.746 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.061 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.495 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.22 146.97 18.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.443 HG23 ' N ' ' A' ' 4' ' ' LYS . 12.0 p 177.52 138.25 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.881 0.848 . . . . 0.0 111.019 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.859 ' C ' ' H ' ' A' ' 6' ' ' ARG . 5.4 ptmm? -126.78 -109.41 0.3 Allowed 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.376 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 36.4 t70 61.99 -37.71 0.13 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.956 1.36 . . . . 0.0 108.549 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.859 ' H ' ' C ' ' A' ' 4' ' ' LYS . 8.1 ttm105 -73.74 -33.8 64.48 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 112.216 -2.265 . . . . 0.0 110.355 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.974 ' O ' ' N ' ' A' ' 10' ' ' LYS . 4.5 p -69.27 -24.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 CA-C-N 111.039 -2.801 . . . . 0.0 111.286 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.505 ' CE ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -31.44 -39.84 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 122.314 1.054 . . . . 0.0 110.844 -177.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.785 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -69.0 0.8 12.68 Favored Glycine 0 C--N 1.299 -1.488 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.723 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.974 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.8 mmmm 46.94 -2.74 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.641 0.734 . . . . 0.0 112.937 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.785 ' H ' ' C ' ' A' ' 9' ' ' GLY . 39.0 t -93.94 -1.94 53.95 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.459 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.916 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.8 t70 -46.83 109.81 1.13 Allowed Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.924 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.928 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 34.1 Cg_endo -71.0 -33.13 12.33 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 123.586 2.857 . . . . 0.0 116.674 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.928 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.21 -46.13 71.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.615 -178.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.47 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.8 m170 -74.72 -26.0 59.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 108.649 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.916 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -64.07 -30.56 71.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.605 -2.088 . . . . 0.0 110.962 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.528 HG21 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.99 -41.72 20.34 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.832 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 22' ' ' SER . 87.7 p -74.32 -18.44 60.7 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 112.018 -2.355 . . . . 0.0 110.226 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -77.28 -59.16 3.17 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.435 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.78 -24.0 55.03 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 23' ' ' PRO . 88.4 mt -102.26 7.44 40.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.637 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 57.2 m 16.52 -74.04 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.819 1.248 . . . . 0.0 114.313 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.637 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 15.8 Cg_endo -54.48 -15.28 8.46 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 C-N-CA 121.69 1.594 . . . . 0.0 112.31 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 22' ' ' SER . . . -63.98 -30.37 71.45 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.014 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.0 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.203 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.875 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.782 0.325 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.64 105.12 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.685 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -158.39 121.26 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.153 0.502 . . . . 0.0 110.694 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.495 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.25 28.44 5.25 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.51 1.148 . . . . 0.0 111.745 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.5 m-20 -100.34 -18.63 16.69 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 112.996 -1.911 . . . . 0.0 106.963 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -75.42 -33.7 60.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.965 177.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.685 ' O ' ' N ' ' A' ' 10' ' ' LYS . 20.9 m -54.67 -26.9 17.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 110.932 -2.849 . . . . 0.0 110.248 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -50.44 -39.75 48.53 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -70.75 4.52 9.49 Favored Glycine 0 C--N 1.308 -1.01 0 CA-C-N 111.581 -2.554 . . . . 0.0 111.1 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.685 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 37.8 5.61 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 9' ' ' GLY . 45.5 t -94.93 -3.81 47.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.784 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.892 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 7.8 t70 -46.75 109.45 1.04 Allowed Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.931 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 37.3 Cg_endo -71.59 -33.48 10.56 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.576 2.85 . . . . 0.0 116.755 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.931 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -66.41 -47.06 74.45 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.045 -177.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.574 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 43.8 m170 -75.08 -25.81 58.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.502 1.144 . . . . 0.0 108.78 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.892 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.06 -30.54 71.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.019 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -84.16 -41.08 17.41 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.723 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.574 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 90.3 p -73.52 -18.7 61.06 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.193 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.09 -59.71 3.56 Favored Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.2 -24.95 57.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 23' ' ' PRO . 88.4 mt -101.31 7.21 42.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.488 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.644 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 51.3 m 16.1 -74.47 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.682 1.193 . . . . 0.0 114.135 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.644 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.3 Cg_endo -54.88 -13.35 6.06 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.862 1.708 . . . . 0.0 112.54 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . -57.28 -31.53 65.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.081 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -105.41 -40.86 5.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.919 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.944 0.402 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.14 -74.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.511 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p 179.6 130.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 111.003 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -122.33 29.19 7.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.605 1.193 . . . . 0.0 111.303 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.629 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 67.4 m-20 -103.89 -14.89 15.83 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.386 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.593 ' HD3' ' CE1' ' A' ' 14' ' ' TYR . 2.3 ttm105 -76.14 -42.64 46.17 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.94 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.754 ' O ' ' N ' ' A' ' 10' ' ' LYS . 3.4 m -56.23 -25.39 19.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 CA-C-N 109.959 -3.291 . . . . 0.0 110.544 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -46.73 -41.52 15.29 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.844 1.307 . . . . 0.0 107.766 177.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.83 2.99 7.11 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.213 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 36.07 8.26 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.742 ' N ' ' O ' ' A' ' 9' ' ' GLY . 44.3 t -95.03 -8.78 35.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.186 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.88 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 11.8 t70 -47.1 108.09 0.82 Allowed Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.945 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 56.3 Cg_endo -73.51 -34.08 6.15 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 123.733 2.955 . . . . 0.0 117.368 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.945 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.97 -46.71 70.6 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.54 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 51.6 m170 -74.94 -25.71 59.08 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.462 1.125 . . . . 0.0 108.669 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.88 ' HB3' ' O ' ' A' ' 12' ' ' ASP . . . -61.81 -32.38 72.67 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.715 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.529 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.0 -41.63 22.43 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.584 -178.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.54 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 91.9 p -70.09 -20.34 63.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.137 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -74.28 -59.37 3.92 Favored Glycine 0 CA--C 1.506 -0.502 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.328 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.6 -24.03 54.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' PRO . 89.7 mt -101.52 7.33 42.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.425 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.654 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 45.1 m 16.34 -74.45 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.585 1.154 . . . . 0.0 113.989 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.654 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 22.3 Cg_endo -56.51 -9.98 4.45 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 121.857 1.705 . . . . 0.0 112.59 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . -56.64 -40.18 74.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.648 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 22' ' ' SER . 18.6 pttp -71.59 -39.11 70.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.957 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 pttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 3' ' ' VAL . . . -121.76 -34.32 0.86 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.821 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 2' ' ' GLY . 3.7 p 46.12 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.729 0.776 . . . . 0.0 112.255 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -128.24 28.56 5.48 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.449 1.119 . . . . 0.0 112.038 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.546 ' C ' ' HG2' ' A' ' 8' ' ' LYS . 59.1 p30 -99.74 -18.12 17.39 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.071 -1.877 . . . . 0.0 107.458 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.479 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 24.7 ttm-85 -76.97 -41.2 44.06 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 111.904 -2.407 . . . . 0.0 111.206 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 12' ' ' ASP . 16.1 m -57.76 -27.92 31.44 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-N 110.693 -2.958 . . . . 0.0 110.806 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HG2' ' C ' ' A' ' 5' ' ' ASP . 7.6 mmmm -63.86 -34.8 78.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.19 0.83 10.21 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 110.392 -3.095 . . . . 0.0 111.074 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.516 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 38.17 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 9' ' ' GLY . 46.4 t -94.52 -9.7 34.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.508 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.906 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.1 t70 -46.93 109.85 1.14 Allowed Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.868 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.932 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 33.2 Cg_endo -71.0 -32.85 12.75 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 123.558 2.839 . . . . 0.0 116.813 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.932 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.54 -46.68 68.88 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.028 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.58 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.3 m170 -74.9 -25.78 59.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.565 1.174 . . . . 0.0 108.602 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.906 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.82 -31.82 72.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.646 -2.07 . . . . 0.0 110.654 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.523 HG21 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.89 -41.61 20.69 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.478 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -69.26 -20.37 63.93 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.893 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.22 -58.22 4.78 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.145 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.83 59.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 23' ' ' PRO . 89.9 mt -100.25 7.19 44.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.349 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.645 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 49.8 m 15.35 -73.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.702 1.201 . . . . 0.0 114.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.645 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.7 Cg_endo -54.88 -13.74 6.75 Favored 'Trans proline' 0 CA--C 1.508 -0.793 0 C-N-CA 121.787 1.658 . . . . 0.0 112.385 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . -58.78 -35.72 73.25 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.87 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -99.58 -40.55 7.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.032 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 t0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.885 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.754 0.311 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.94 96.83 0.41 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.78 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.427 ' O ' ' CE1' ' A' ' 15' ' ' HIS . 42.4 t -157.7 119.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.792 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.538 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -136.67 21.98 3.11 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.318 1.056 . . . . 0.0 111.296 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -95.35 -13.75 24.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.105 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.62 ' O ' ' HD3' ' A' ' 8' ' ' LYS . 7.3 ttt85 -74.37 -31.68 62.47 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.28 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.964 ' O ' ' N ' ' A' ' 9' ' ' GLY . 2.8 p -67.59 -29.28 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 110.858 -2.883 . . . . 0.0 110.558 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 4.25 -51.17 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.924 1.39 . . . . 0.0 111.948 -177.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.964 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -75.55 8.3 20.67 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.418 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.887 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.3 mmmt 46.6 -4.88 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.786 ' H ' ' C ' ' A' ' 9' ' ' GLY . 35.8 t -94.66 -1.04 53.86 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.491 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.954 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 7.2 t70 -46.4 111.53 1.52 Allowed Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.27 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.862 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 24.1 Cg_endo -69.06 -30.56 25.34 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 123.732 2.955 . . . . 0.0 116.693 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.862 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -73.06 -46.11 53.54 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.35 -178.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.541 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 61.0 m170 -74.46 -25.58 59.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.495 1.141 . . . . 0.0 108.365 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.954 ' HB1' ' O ' ' A' ' 12' ' ' ASP . . . -61.97 -32.42 72.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.577 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -79.96 -41.93 24.99 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.559 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 82.5 p -70.98 -19.52 62.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.175 -2.284 . . . . 0.0 109.975 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.11 -57.51 4.34 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -24.6 58.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' A' ' 23' ' ' PRO . 91.3 mt -100.3 7.27 44.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.382 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.664 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 44.8 m 15.89 -74.32 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.59 1.156 . . . . 0.0 113.814 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.664 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 20.3 Cg_endo -55.77 -9.76 3.23 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 121.957 1.771 . . . . 0.0 112.553 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 22' ' ' SER . . . -56.35 -38.23 71.1 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -59.68 -31.79 69.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.818 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.045 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.42 -179.08 48.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.606 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -159.09 123.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 0.0 110.775 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' O ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.89 27.12 6.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.788 1.28 . . . . 0.0 111.433 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.546 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 8.1 m-20 -97.18 -21.2 17.45 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.482 -2.144 . . . . 0.0 107.301 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.473 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.19 -36.19 61.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.025 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 10' ' ' LYS . 13.2 m -55.65 -27.39 21.56 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-N 110.607 -2.997 . . . . 0.0 110.215 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -51.42 -39.64 57.7 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.933 1.349 . . . . 0.0 107.366 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.744 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -67.69 1.86 7.0 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 111.546 -2.57 . . . . 0.0 111.252 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 37.3 8.32 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.744 ' N ' ' O ' ' A' ' 9' ' ' GLY . 47.0 t -94.59 -6.02 44.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.37 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.9 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 13.2 t70 -46.81 109.3 1.01 Allowed Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.205 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.937 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 46.9 Cg_endo -72.1 -33.56 9.35 Favored 'Trans proline' 0 C--N 1.327 -0.564 0 C-N-CA 123.614 2.876 . . . . 0.0 116.622 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.937 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.29 -46.42 73.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.787 -177.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.524 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 55.8 m170 -74.92 -25.8 59.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.517 1.151 . . . . 0.0 108.765 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.9 ' HB1' ' O ' ' A' ' 12' ' ' ASP . . . -63.37 -30.82 71.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.025 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.534 HG21 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 -41.8 18.67 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.66 -1.609 . . . . 0.0 108.694 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 22' ' ' SER . 85.7 p -73.89 -17.27 61.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.157 -2.292 . . . . 0.0 110.054 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.84 -63.07 2.96 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.33 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.43 -24.97 58.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.609 ' O ' ' N ' ' A' ' 24' ' ' ALA . 93.9 mt -97.63 8.23 45.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.496 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.813 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.1 m 5.59 -64.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.813 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 48.6 Cg_exo -59.6 -9.72 9.8 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 121.541 1.494 . . . . 0.0 111.772 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . -57.14 -36.78 71.12 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 111.976 -2.374 . . . . 0.0 111.15 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 10.7 mtmp? -60.46 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.9 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.842 0.354 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.29 -171.55 21.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.65 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 p 175.94 136.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 110.279 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -102.37 18.13 21.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.23 1.014 . . . . 0.0 112.074 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 51.1 m-20 -99.99 -12.06 20.08 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 113.464 -1.698 . . . . 0.0 106.486 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.541 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 17.2 ttm180 -74.97 -34.45 62.03 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 112.711 -2.041 . . . . 0.0 109.572 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 10' ' ' LYS . 8.1 p -67.54 -25.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.061 0 CA-C-N 110.296 -3.138 . . . . 0.0 111.34 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.541 ' CE ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -30.57 -39.97 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.215 1.007 . . . . 0.0 110.685 -177.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.784 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -68.29 2.56 7.04 Favored Glycine 0 C--N 1.3 -1.446 0 CA-C-N 113.23 -1.805 . . . . 0.0 110.816 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.956 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.2 mmtt 45.78 -2.54 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 113.057 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.784 ' H ' ' C ' ' A' ' 9' ' ' GLY . 69.2 m -94.02 -1.35 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.473 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.922 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.2 t70 -46.89 110.47 1.28 Allowed Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.805 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.914 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 20.3 Cg_endo -69.64 -32.72 18.5 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 123.516 2.811 . . . . 0.0 116.526 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.914 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.22 -46.39 67.51 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.626 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 19' ' ' GLY . 57.8 m170 -74.76 -25.74 59.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.447 1.118 . . . . 0.0 108.624 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.922 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.47 -30.59 71.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.087 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.97 -41.77 18.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.741 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' SER . 88.0 p -74.96 -17.0 60.62 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 112.232 -2.258 . . . . 0.0 110.237 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.98 -62.84 2.85 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.434 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.82 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.593 ' O ' ' N ' ' A' ' 24' ' ' ALA . 92.3 mt -98.79 8.19 45.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.6 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.833 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 7.16 -65.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.833 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 49.2 Cg_exo -59.55 -9.53 9.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.589 1.526 . . . . 0.0 111.745 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . -59.34 -40.07 85.18 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.006 -2.361 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -89.0 -29.44 19.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.883 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.794 0.331 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.77 104.2 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.798 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -178.79 128.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 111.223 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.613 ' HD2' ' C ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -114.24 11.98 17.58 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 122.204 1.002 . . . . 0.0 111.805 -179.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -94.63 -14.14 25.22 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.592 ' HA ' ' NZ ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -74.3 -30.6 62.15 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.669 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.761 ' O ' ' N ' ' A' ' 10' ' ' LYS . 8.9 p -57.19 -26.25 25.06 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.876 0 CA-C-N 111.07 -2.786 . . . . 0.0 111.908 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.592 ' NZ ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -46.64 -35.23 5.75 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.741 1.258 . . . . 0.0 109.491 -179.154 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -76.36 4.17 50.32 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.784 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.761 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 39.5 7.52 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 9' ' ' GLY . 68.8 m -94.59 -3.19 50.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.992 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.931 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.3 t70 -46.41 111.26 1.43 Allowed Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.409 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.876 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -69.17 -32.62 20.64 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 C-N-CA 123.555 2.836 . . . . 0.0 116.518 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.876 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.77 -46.2 66.34 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.52 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.519 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 58.0 m170 -74.64 -26.33 59.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.551 1.167 . . . . 0.0 108.463 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 12' ' ' ASP . . . -62.07 -31.81 72.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.806 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -80.72 -42.02 22.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.595 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -72.04 -18.09 61.98 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.065 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.75 -62.5 3.18 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.373 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.29 56.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' A' ' 24' ' ' ALA . 95.2 mt -98.08 8.23 45.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.455 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.819 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.7 m 5.45 -64.26 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.819 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 51.1 Cg_exo -59.14 -9.74 8.82 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 121.672 1.581 . . . . 0.0 111.703 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . -56.91 -24.39 51.9 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 111.955 -2.384 . . . . 0.0 111.279 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 10.6 mtmp? -51.14 -89.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.351 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.2 t0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.872 -179.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.859 0.362 . . . . 0.0 110.645 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.48 67.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.431 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.499 ' CG2' ' H ' ' A' ' 4' ' ' LYS . 8.7 p -122.52 -140.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.521 ' O ' ' CG1' ' A' ' 7' ' ' VAL . 0.6 OUTLIER -79.61 6.84 9.54 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.937 0.875 . . . . 0.0 112.02 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.4 -11.84 50.83 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 8' ' ' LYS . 16.0 ttm-85 -73.89 -28.96 61.82 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.161 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.048 ' O ' ' N ' ' A' ' 10' ' ' LYS . 1.8 p -67.93 -28.36 41.04 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 111.032 -2.804 . . . . 0.0 110.904 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.558 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -8.38 -48.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.649 1.218 . . . . 0.0 111.874 -177.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -74.64 9.04 11.58 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.548 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 1.048 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 39.45 3.01 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.778 ' H ' ' C ' ' A' ' 9' ' ' GLY . 41.2 t -95.5 -3.03 47.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.35 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.9 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 8.0 t70 -46.35 109.48 1.01 Allowed Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.268 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.942 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 44.2 Cg_endo -72.12 -34.01 8.75 Favored 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 123.597 2.865 . . . . 0.0 116.774 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.942 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -65.42 -46.72 78.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.481 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.641 ' O ' ' N ' ' A' ' 19' ' ' GLY . 57.5 m170 -75.4 -25.2 57.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.398 1.094 . . . . 0.0 109.307 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.9 ' HB1' ' O ' ' A' ' 12' ' ' ASP . . . -66.55 -27.77 68.0 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.805 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -88.94 -40.88 12.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.971 -178.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 22' ' ' SER . 77.2 p -82.04 -13.57 57.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.345 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -76.44 -62.9 2.46 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.193 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.17 60.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.59 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.5 mt -96.88 8.15 45.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.586 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.871 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 8.88 -66.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 45.9 Cg_exo -60.14 -8.47 8.28 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 122.004 1.803 . . . . 0.0 111.938 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . -56.12 -40.09 73.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.725 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 22' ' ' SER . 45.7 pttt -56.28 -29.55 61.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 111.051 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.922 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.43 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.55 -151.24 15.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.409 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t 63.18 127.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 111.326 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.511 ' NZ ' ' HB2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -122.05 12.06 10.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 122.24 1.019 . . . . 0.0 111.621 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 53.4 m-20 -95.55 -11.55 27.19 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 113.662 -1.608 . . . . 0.0 106.662 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 16.3 ttm-85 -75.42 -36.48 60.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 112.94 -1.936 . . . . 0.0 109.392 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.013 ' O ' ' N ' ' A' ' 10' ' ' LYS . 8.6 p -70.51 -24.84 25.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.007 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.135 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.592 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -27.4 -42.11 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.254 1.026 . . . . 0.0 110.898 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.78 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -70.88 5.17 8.17 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.898 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 1.013 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 40.02 3.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.78 ' H ' ' C ' ' A' ' 9' ' ' GLY . 40.0 t -95.16 -0.88 52.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.892 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 6.3 t70 -46.17 109.54 1.01 Allowed Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.783 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.953 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 28.6 Cg_endo -70.61 -33.16 13.81 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 123.394 2.729 . . . . 0.0 116.54 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.953 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -64.89 -46.62 80.98 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.555 -178.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.668 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.4 m170 -74.9 -25.76 59.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.578 1.18 . . . . 0.0 109.343 176.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.892 ' HB1' ' O ' ' A' ' 12' ' ' ASP . . . -69.17 -28.55 66.51 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.608 -2.087 . . . . 0.0 111.483 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 13' ' ' PRO . 1.2 m -98.35 -20.67 17.04 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.521 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.668 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -96.65 -15.87 21.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.686 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.15 -62.43 2.76 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.268 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 -25.07 58.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.612 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 79.6 mt -98.91 8.18 45.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.551 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.816 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.4 m 8.26 -65.76 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.816 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 43.0 Cg_exo -60.26 -9.24 10.07 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 121.53 1.487 . . . . 0.0 111.746 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 21' ' ' LEU . . . -58.67 -40.21 82.89 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.282 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.517 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -85.35 -22.97 28.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.861 179.908 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HE3' ' H ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 122.314 1.054 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.74 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -69.0 0.8 12.68 Favored Glycine 0 C--N 1.299 -1.488 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.723 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 5.8 mmmm 46.94 -2.74 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.641 0.734 . . . . 0.0 112.937 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.74 ' H ' ' C ' ' A' ' 9' ' ' GLY . 39.0 t -93.94 -1.94 53.95 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.459 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.799 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.8 t70 -46.83 109.81 1.13 Allowed Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.924 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.935 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 34.1 Cg_endo -71.0 -33.13 12.33 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 123.586 2.857 . . . . 0.0 116.674 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.935 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.21 -46.13 71.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.615 -178.026 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.501 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.8 m170 -74.72 -26.0 59.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 108.649 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.799 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -64.07 -30.56 71.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.605 -2.088 . . . . 0.0 110.962 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.99 -41.72 20.34 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.832 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 87.7 p -74.32 -18.44 60.7 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 112.018 -2.355 . . . . 0.0 110.226 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -77.28 -59.16 3.17 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.435 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.78 -24.0 55.03 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.734 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 88.4 mt -102.26 7.44 40.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.659 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 57.2 m 16.52 -74.04 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.819 1.248 . . . . 0.0 114.313 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.659 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 15.8 Cg_endo -54.48 -15.28 8.46 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 C-N-CA 121.69 1.594 . . . . 0.0 112.31 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.844 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.014 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.494 -1.176 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -70.75 4.52 9.49 Favored Glycine 0 C--N 1.308 -1.01 0 CA-C-N 111.581 -2.554 . . . . 0.0 111.1 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 37.8 5.61 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 9' ' ' GLY . 45.5 t -94.93 -3.81 47.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.784 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 7.8 t70 -46.75 109.45 1.04 Allowed Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.941 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 37.3 Cg_endo -71.59 -33.48 10.56 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.576 2.85 . . . . 0.0 116.755 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.941 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -66.41 -47.06 74.45 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.045 -177.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.612 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 43.8 m170 -75.08 -25.81 58.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.502 1.144 . . . . 0.0 108.78 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.06 -30.54 71.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.019 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -84.16 -41.08 17.41 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.723 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 90.3 p -73.52 -18.7 61.06 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.193 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.09 -59.71 3.56 Favored Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.2 -24.95 57.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 88.4 mt -101.31 7.21 42.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.488 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.665 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 51.3 m 16.1 -74.47 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.682 1.193 . . . . 0.0 114.135 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.665 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.3 Cg_endo -54.88 -13.35 6.06 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.862 1.708 . . . . 0.0 112.54 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.792 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.081 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.495 -1.14 0 CA-C-O 122.844 1.307 . . . . 0.0 107.766 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.83 2.99 7.11 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.213 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 36.07 8.26 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.742 ' N ' ' O ' ' A' ' 9' ' ' GLY . 44.3 t -95.03 -8.78 35.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.186 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.826 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 11.8 t70 -47.1 108.09 0.82 Allowed Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.949 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 56.3 Cg_endo -73.51 -34.08 6.15 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 123.733 2.955 . . . . 0.0 117.368 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.949 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.97 -46.71 70.6 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.607 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 51.6 m170 -74.94 -25.71 59.08 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.462 1.125 . . . . 0.0 108.669 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.826 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.81 -32.38 72.67 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.715 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.0 -41.63 22.43 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.584 -178.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.607 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 91.9 p -70.09 -20.34 63.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.137 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -74.28 -59.37 3.92 Favored Glycine 0 CA--C 1.506 -0.502 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.328 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.6 -24.03 54.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.808 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 89.7 mt -101.52 7.33 42.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.425 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.677 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 45.1 m 16.34 -74.45 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.585 1.154 . . . . 0.0 113.989 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.677 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 22.3 Cg_endo -56.51 -9.98 4.45 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 121.857 1.705 . . . . 0.0 112.59 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.808 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.81 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.648 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 7.6 mmmm . . . . . 0 CA--C 1.483 -1.609 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.19 0.83 10.21 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 110.392 -3.095 . . . . 0.0 111.074 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 38.17 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 9' ' ' GLY . 46.4 t -94.52 -9.7 34.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.508 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.802 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.1 t70 -46.93 109.85 1.14 Allowed Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.868 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.935 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 33.2 Cg_endo -71.0 -32.85 12.75 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 123.558 2.839 . . . . 0.0 116.813 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.935 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.54 -46.68 68.88 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.028 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.643 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.3 m170 -74.9 -25.78 59.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.565 1.174 . . . . 0.0 108.602 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.82 -31.82 72.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.646 -2.07 . . . . 0.0 110.654 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.89 -41.61 20.69 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.478 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.643 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -69.26 -20.37 63.93 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.893 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.22 -58.22 4.78 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.145 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.83 59.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.79 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 89.9 mt -100.25 7.19 44.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.349 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.665 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 49.8 m 15.35 -73.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.702 1.201 . . . . 0.0 114.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.665 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.7 Cg_endo -54.88 -13.74 6.75 Favored 'Trans proline' 0 CA--C 1.508 -0.793 0 C-N-CA 121.787 1.658 . . . . 0.0 112.385 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.79 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.847 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.87 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.562 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.654 0 CA-C-O 121.574 0.702 . . . . 0.0 111.948 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.77 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -75.55 8.3 20.67 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.418 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt 46.6 -4.88 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.77 ' H ' ' C ' ' A' ' 9' ' ' GLY . 35.8 t -94.66 -1.04 53.86 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.491 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.839 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 7.2 t70 -46.4 111.53 1.52 Allowed Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.27 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.863 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 24.1 Cg_endo -69.06 -30.56 25.34 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 123.732 2.955 . . . . 0.0 116.693 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.863 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -73.06 -46.11 53.54 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.35 -178.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.592 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 61.0 m170 -74.46 -25.58 59.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.495 1.141 . . . . 0.0 108.365 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.97 -32.42 72.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.577 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -79.96 -41.93 24.99 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.559 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 82.5 p -70.98 -19.52 62.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.175 -2.284 . . . . 0.0 109.975 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.11 -57.51 4.34 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -24.6 58.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 91.3 mt -100.3 7.27 44.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.382 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.685 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 44.8 m 15.89 -74.32 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.59 1.156 . . . . 0.0 113.814 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.685 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 20.3 Cg_endo -55.77 -9.76 3.23 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 121.957 1.771 . . . . 0.0 112.553 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.806 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.431 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.566 ' O ' ' HD2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.286 0 CA-C-O 122.933 1.349 . . . . 0.0 107.366 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.744 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -67.69 1.86 7.0 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 111.546 -2.57 . . . . 0.0 111.252 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 37.3 8.32 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.744 ' N ' ' O ' ' A' ' 9' ' ' GLY . 47.0 t -94.59 -6.02 44.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.37 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.793 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 13.2 t70 -46.81 109.3 1.01 Allowed Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.205 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.946 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 46.9 Cg_endo -72.1 -33.56 9.35 Favored 'Trans proline' 0 C--N 1.327 -0.564 0 C-N-CA 123.614 2.876 . . . . 0.0 116.622 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.946 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.29 -46.42 73.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.787 -177.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.56 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 55.8 m170 -74.92 -25.8 59.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.517 1.151 . . . . 0.0 108.765 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.793 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.37 -30.82 71.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.025 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 -41.8 18.67 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.66 -1.609 . . . . 0.0 108.694 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.7 p -73.89 -17.27 61.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.157 -2.292 . . . . 0.0 110.054 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.84 -63.07 2.96 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.33 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.43 -24.97 58.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.726 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 93.9 mt -97.63 8.23 45.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.496 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.832 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.1 m 5.59 -64.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.832 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 48.6 Cg_exo -59.6 -9.72 9.8 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 121.541 1.494 . . . . 0.0 111.772 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 111.976 -2.374 . . . . 0.0 111.15 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.929 0 CA-C-O 122.215 1.007 . . . . 0.0 110.685 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.741 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -68.29 2.56 7.04 Favored Glycine 0 C--N 1.3 -1.446 0 CA-C-N 113.23 -1.805 . . . . 0.0 110.816 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 4.2 mmtt 45.78 -2.54 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 113.057 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.741 ' H ' ' C ' ' A' ' 9' ' ' GLY . 69.2 m -94.02 -1.35 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.473 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.804 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.2 t70 -46.89 110.47 1.28 Allowed Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.805 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.92 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 20.3 Cg_endo -69.64 -32.72 18.5 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 123.516 2.811 . . . . 0.0 116.526 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.92 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.22 -46.39 67.51 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.626 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.532 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.8 m170 -74.76 -25.74 59.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.447 1.118 . . . . 0.0 108.624 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.804 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.47 -30.59 71.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.087 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.97 -41.77 18.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.741 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.532 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -74.96 -17.0 60.62 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 112.232 -2.258 . . . . 0.0 110.237 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.98 -62.84 2.85 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.434 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.82 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 92.3 mt -98.79 8.19 45.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.6 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.863 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 7.16 -65.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 49.2 Cg_exo -59.55 -9.53 9.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.589 1.526 . . . . 0.0 111.745 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.04 0 CA-C-N 112.006 -2.361 . . . . 0.0 111.112 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.563 ' HE3' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.902 0 CA-C-O 122.741 1.258 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -76.36 4.17 50.32 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.784 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.438 ' CD ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 39.5 7.52 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 9' ' ' GLY . 68.8 m -94.59 -3.19 50.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.992 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.798 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 8.3 t70 -46.41 111.26 1.43 Allowed Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.409 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.876 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -69.17 -32.62 20.64 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 C-N-CA 123.555 2.836 . . . . 0.0 116.518 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.876 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.77 -46.2 66.34 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.52 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.566 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 58.0 m170 -74.64 -26.33 59.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.551 1.167 . . . . 0.0 108.463 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -62.07 -31.81 72.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.806 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -80.72 -42.02 22.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.595 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -72.04 -18.09 61.98 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.065 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.75 -62.5 3.18 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.373 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.29 56.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.704 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 95.2 mt -98.08 8.23 45.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.455 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.844 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.7 m 5.45 -64.26 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 51.1 Cg_exo -59.14 -9.74 8.82 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 121.672 1.581 . . . . 0.0 111.703 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.704 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.046 0 CA-C-N 111.955 -2.384 . . . . 0.0 111.279 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.757 0 CA-C-O 121.803 0.811 . . . . 0.0 111.874 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.764 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -74.64 9.04 11.58 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.548 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' CD ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 39.45 3.01 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 9' ' ' GLY . 41.2 t -95.5 -3.03 47.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.35 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.789 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 8.0 t70 -46.35 109.48 1.01 Allowed Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.268 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.955 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 44.2 Cg_endo -72.12 -34.01 8.75 Favored 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 123.597 2.865 . . . . 0.0 116.774 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.955 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -65.42 -46.72 78.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.481 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.641 ' O ' ' N ' ' A' ' 19' ' ' GLY . 57.5 m170 -75.4 -25.2 57.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.398 1.094 . . . . 0.0 109.307 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -66.55 -27.77 68.0 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.805 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -88.94 -40.88 12.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.971 -178.162 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 77.2 p -82.04 -13.57 57.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.345 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -76.44 -62.9 2.46 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.193 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.17 60.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 85.5 mt -96.88 8.15 45.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.586 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.901 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 8.88 -66.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 45.9 Cg_exo -60.14 -8.47 8.28 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 122.004 1.803 . . . . 0.0 111.938 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.059 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.725 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.93 0 CA-C-O 122.254 1.026 . . . . 0.0 110.898 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.768 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -70.88 5.17 8.17 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.898 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 40.02 3.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.768 ' H ' ' C ' ' A' ' 9' ' ' GLY . 40.0 t -95.16 -0.88 52.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.721 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.3 t70 -46.17 109.54 1.01 Allowed Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.783 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.967 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 28.6 Cg_endo -70.61 -33.16 13.81 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 123.394 2.729 . . . . 0.0 116.54 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.967 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -64.89 -46.62 80.98 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.555 -178.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.696 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.4 m170 -74.9 -25.76 59.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.578 1.18 . . . . 0.0 109.343 176.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -69.17 -28.55 66.51 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.608 -2.087 . . . . 0.0 111.483 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.566 ' O ' HD12 ' A' ' 21' ' ' LEU . 1.2 m -98.35 -20.67 17.04 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.521 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.696 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -96.65 -15.87 21.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.686 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.15 -62.43 2.76 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.268 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 -25.07 58.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 79.6 mt -98.91 8.18 45.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.551 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.863 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.4 m 8.26 -65.76 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 43.0 Cg_exo -60.26 -9.24 10.07 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 121.53 1.487 . . . . 0.0 111.746 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.061 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.499 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.22 146.97 18.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p 177.52 138.25 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.881 0.848 . . . . 0.0 111.019 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.894 ' C ' ' H ' ' A' ' 6' ' ' ARG . 5.4 ptmm? -126.78 -109.41 0.3 Allowed 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.376 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 36.4 t70 61.99 -37.71 0.13 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.956 1.36 . . . . 0.0 108.549 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.894 ' H ' ' C ' ' A' ' 4' ' ' LYS . 8.1 ttm105 -73.74 -33.8 64.48 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 112.216 -2.265 . . . . 0.0 110.355 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.974 ' O ' ' N ' ' A' ' 10' ' ' LYS . 4.5 p -69.27 -24.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 CA-C-N 111.039 -2.801 . . . . 0.0 111.286 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HE3' ' H ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -31.44 -39.84 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 122.314 1.054 . . . . 0.0 110.844 -177.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.74 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -69.0 0.8 12.68 Favored Glycine 0 C--N 1.299 -1.488 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.723 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.974 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.8 mmmm 46.94 -2.74 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.641 0.734 . . . . 0.0 112.937 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.74 ' H ' ' C ' ' A' ' 9' ' ' GLY . 39.0 t -93.94 -1.94 53.95 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.459 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.799 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.8 t70 -46.83 109.81 1.13 Allowed Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.924 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.935 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 34.1 Cg_endo -71.0 -33.13 12.33 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 123.586 2.857 . . . . 0.0 116.674 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.935 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.21 -46.13 71.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.615 -178.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.501 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.8 m170 -74.72 -26.0 59.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 108.649 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.799 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -64.07 -30.56 71.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.605 -2.088 . . . . 0.0 110.962 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.99 -41.72 20.34 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.832 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 87.7 p -74.32 -18.44 60.7 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 112.018 -2.355 . . . . 0.0 110.226 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -77.28 -59.16 3.17 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.435 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.78 -24.0 55.03 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.734 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 88.4 mt -102.26 7.44 40.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.659 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 57.2 m 16.52 -74.04 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.819 1.248 . . . . 0.0 114.313 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.659 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 15.8 Cg_endo -54.48 -15.28 8.46 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 C-N-CA 121.69 1.594 . . . . 0.0 112.31 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -63.98 -30.37 71.45 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.014 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.0 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.203 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.875 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.782 0.325 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.64 105.12 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.685 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -158.39 121.26 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.153 0.502 . . . . 0.0 110.694 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.25 28.44 5.25 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.51 1.148 . . . . 0.0 111.745 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.5 m-20 -100.34 -18.63 16.69 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 112.996 -1.911 . . . . 0.0 106.963 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -75.42 -33.7 60.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.965 177.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 4' ' ' LYS . 20.9 m -54.67 -26.9 17.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 110.932 -2.849 . . . . 0.0 110.248 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -50.44 -39.75 48.53 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -70.75 4.52 9.49 Favored Glycine 0 C--N 1.308 -1.01 0 CA-C-N 111.581 -2.554 . . . . 0.0 111.1 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.685 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 37.8 5.61 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 9' ' ' GLY . 45.5 t -94.93 -3.81 47.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.784 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 7.8 t70 -46.75 109.45 1.04 Allowed Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.941 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 37.3 Cg_endo -71.59 -33.48 10.56 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.576 2.85 . . . . 0.0 116.755 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.941 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -66.41 -47.06 74.45 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.045 -177.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.612 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 43.8 m170 -75.08 -25.81 58.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.502 1.144 . . . . 0.0 108.78 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.06 -30.54 71.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.019 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -84.16 -41.08 17.41 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.723 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 90.3 p -73.52 -18.7 61.06 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.193 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.09 -59.71 3.56 Favored Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.2 -24.95 57.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 88.4 mt -101.31 7.21 42.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.488 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.665 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 51.3 m 16.1 -74.47 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.682 1.193 . . . . 0.0 114.135 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.665 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.3 Cg_endo -54.88 -13.35 6.06 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.862 1.708 . . . . 0.0 112.54 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -57.28 -31.53 65.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.081 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -105.41 -40.86 5.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.919 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.944 0.402 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.14 -74.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.511 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.581 HG22 ' H ' ' A' ' 5' ' ' ASP . 7.1 p 179.6 130.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 111.003 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.518 ' C ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -122.33 29.19 7.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.605 1.193 . . . . 0.0 111.303 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.644 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 67.4 m-20 -103.89 -14.89 15.83 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.386 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.61 ' HD3' ' CE1' ' A' ' 14' ' ' TYR . 2.3 ttm105 -76.14 -42.64 46.17 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.94 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.754 ' O ' ' N ' ' A' ' 10' ' ' LYS . 3.4 m -56.23 -25.39 19.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 CA-C-N 109.959 -3.291 . . . . 0.0 110.544 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -46.73 -41.52 15.29 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.844 1.307 . . . . 0.0 107.766 177.261 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.83 2.99 7.11 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.213 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 36.07 8.26 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.742 ' N ' ' O ' ' A' ' 9' ' ' GLY . 44.3 t -95.03 -8.78 35.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.186 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.826 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 11.8 t70 -47.1 108.09 0.82 Allowed Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.949 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 56.3 Cg_endo -73.51 -34.08 6.15 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 123.733 2.955 . . . . 0.0 117.368 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.949 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.97 -46.71 70.6 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.607 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 51.6 m170 -74.94 -25.71 59.08 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.462 1.125 . . . . 0.0 108.669 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.826 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.81 -32.38 72.67 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.715 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.0 -41.63 22.43 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.584 -178.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.607 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 91.9 p -70.09 -20.34 63.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.137 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -74.28 -59.37 3.92 Favored Glycine 0 CA--C 1.506 -0.502 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.328 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.6 -24.03 54.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.808 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 89.7 mt -101.52 7.33 42.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.425 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.677 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 45.1 m 16.34 -74.45 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.585 1.154 . . . . 0.0 113.989 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.677 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 22.3 Cg_endo -56.51 -9.98 4.45 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 121.857 1.705 . . . . 0.0 112.59 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.808 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -56.64 -40.18 74.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.648 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 22' ' ' SER . 18.6 pttp -71.59 -39.11 70.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.957 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 pttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 3' ' ' VAL . . . -121.76 -34.32 0.86 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.821 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 2' ' ' GLY . 3.7 p 46.12 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.729 0.776 . . . . 0.0 112.255 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.603 ' C ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -128.24 28.56 5.48 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.449 1.119 . . . . 0.0 112.038 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.574 ' C ' ' HG2' ' A' ' 8' ' ' LYS . 59.1 p30 -99.74 -18.12 17.39 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.071 -1.877 . . . . 0.0 107.458 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HD2' ' OD1' ' A' ' 12' ' ' ASP . 24.7 ttm-85 -76.97 -41.2 44.06 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 111.904 -2.407 . . . . 0.0 111.206 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.917 HG23 ' HD2' ' A' ' 8' ' ' LYS . 16.1 m -57.76 -27.92 31.44 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-N 110.693 -2.958 . . . . 0.0 110.806 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.917 ' HD2' HG23 ' A' ' 7' ' ' VAL . 7.6 mmmm -63.86 -34.8 78.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.19 0.83 10.21 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 110.392 -3.095 . . . . 0.0 111.074 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 38.17 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 9' ' ' GLY . 46.4 t -94.52 -9.7 34.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.508 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.802 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.1 t70 -46.93 109.85 1.14 Allowed Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.868 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.935 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 33.2 Cg_endo -71.0 -32.85 12.75 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 123.558 2.839 . . . . 0.0 116.813 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.935 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.54 -46.68 68.88 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.028 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.643 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.3 m170 -74.9 -25.78 59.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.565 1.174 . . . . 0.0 108.602 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.82 -31.82 72.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.646 -2.07 . . . . 0.0 110.654 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.89 -41.61 20.69 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.478 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.643 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -69.26 -20.37 63.93 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.893 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.22 -58.22 4.78 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.145 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.83 59.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.79 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 89.9 mt -100.25 7.19 44.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.349 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.665 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 49.8 m 15.35 -73.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.702 1.201 . . . . 0.0 114.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.665 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.7 Cg_endo -54.88 -13.74 6.75 Favored 'Trans proline' 0 CA--C 1.508 -0.793 0 C-N-CA 121.787 1.658 . . . . 0.0 112.385 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.79 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -58.78 -35.72 73.25 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.87 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -99.58 -40.55 7.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.032 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 t0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.885 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.754 0.311 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.94 96.83 0.41 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.78 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.4 t -157.7 119.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.792 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.905 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -136.67 21.98 3.11 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.318 1.056 . . . . 0.0 111.296 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -95.35 -13.75 24.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.105 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.643 ' O ' ' HD3' ' A' ' 8' ' ' LYS . 7.3 ttt85 -74.37 -31.68 62.47 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.28 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.964 ' O ' ' N ' ' A' ' 9' ' ' GLY . 2.8 p -67.59 -29.28 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 110.858 -2.883 . . . . 0.0 110.558 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.643 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 4.25 -51.17 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.924 1.39 . . . . 0.0 111.948 -177.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.964 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -75.55 8.3 20.67 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.418 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.887 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.3 mmmt 46.6 -4.88 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.77 ' H ' ' C ' ' A' ' 9' ' ' GLY . 35.8 t -94.66 -1.04 53.86 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.491 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.931 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 7.2 t70 -46.4 111.53 1.52 Allowed Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.27 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.863 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 24.1 Cg_endo -69.06 -30.56 25.34 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 123.732 2.955 . . . . 0.0 116.693 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.863 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -73.06 -46.11 53.54 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.35 -178.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.592 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 4.0 m-70 -74.46 -25.58 59.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.495 1.141 . . . . 0.0 108.365 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.97 -32.42 72.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.577 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -79.96 -41.93 24.99 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.559 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 82.5 p -70.98 -19.52 62.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.175 -2.284 . . . . 0.0 109.975 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.11 -57.51 4.34 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -24.6 58.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 91.3 mt -100.3 7.27 44.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.382 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.685 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 44.8 m 15.89 -74.32 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.59 1.156 . . . . 0.0 113.814 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.685 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 20.3 Cg_endo -55.77 -9.76 3.23 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 121.957 1.771 . . . . 0.0 112.553 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -56.35 -38.23 71.1 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -59.68 -31.79 69.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.818 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.045 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.42 -179.08 48.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.606 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -159.09 123.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 0.0 110.775 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.802 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.89 27.12 6.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.788 1.28 . . . . 0.0 111.433 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.567 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 8.1 m-20 -97.18 -21.2 17.45 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.482 -2.144 . . . . 0.0 107.301 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.19 -36.19 61.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.025 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 4' ' ' LYS . 13.2 m -55.65 -27.39 21.56 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-N 110.607 -2.997 . . . . 0.0 110.215 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -51.42 -39.64 57.7 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.933 1.349 . . . . 0.0 107.366 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.744 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -67.69 1.86 7.0 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 111.546 -2.57 . . . . 0.0 111.252 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 37.3 8.32 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.744 ' N ' ' O ' ' A' ' 9' ' ' GLY . 47.0 t -94.59 -6.02 44.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.37 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.793 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 13.2 t70 -46.81 109.3 1.01 Allowed Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.205 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.946 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 46.9 Cg_endo -72.1 -33.56 9.35 Favored 'Trans proline' 0 C--N 1.327 -0.564 0 C-N-CA 123.614 2.876 . . . . 0.0 116.622 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.946 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.29 -46.42 73.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.787 -177.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.56 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 55.8 m170 -74.92 -25.8 59.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.517 1.151 . . . . 0.0 108.765 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.793 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.37 -30.82 71.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.025 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 -41.8 18.67 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.66 -1.609 . . . . 0.0 108.694 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.7 p -73.89 -17.27 61.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.157 -2.292 . . . . 0.0 110.054 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.84 -63.07 2.96 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.33 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.43 -24.97 58.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.726 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 93.9 mt -97.63 8.23 45.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.496 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.832 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.1 m 5.59 -64.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.832 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 48.6 Cg_exo -59.6 -9.72 9.8 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 121.541 1.494 . . . . 0.0 111.772 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -57.14 -36.78 71.12 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 111.976 -2.374 . . . . 0.0 111.15 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 10.7 mtmp? -60.46 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.9 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.842 0.354 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.29 -171.55 21.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.65 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.859 HG22 ' H ' ' A' ' 5' ' ' ASP . 11.4 p 175.94 136.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 110.279 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.869 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -102.37 18.13 21.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.23 1.014 . . . . 0.0 112.074 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.859 ' H ' HG22 ' A' ' 3' ' ' VAL . 51.1 m-20 -99.99 -12.06 20.08 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 113.464 -1.698 . . . . 0.0 106.486 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.541 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 17.2 ttm180 -74.97 -34.45 62.03 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 112.711 -2.041 . . . . 0.0 109.572 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 10' ' ' LYS . 8.1 p -67.54 -25.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.061 0 CA-C-N 110.296 -3.138 . . . . 0.0 111.34 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.541 ' CE ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -30.57 -39.97 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.215 1.007 . . . . 0.0 110.685 -177.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.741 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -68.29 2.56 7.04 Favored Glycine 0 C--N 1.3 -1.446 0 CA-C-N 113.23 -1.805 . . . . 0.0 110.816 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.956 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.2 mmtt 45.78 -2.54 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 113.057 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.741 ' H ' ' C ' ' A' ' 9' ' ' GLY . 69.2 m -94.02 -1.35 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.473 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.842 ' CB ' HG23 ' A' ' 7' ' ' VAL . 6.2 t70 -46.89 110.47 1.28 Allowed Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.805 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.92 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 20.3 Cg_endo -69.64 -32.72 18.5 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 123.516 2.811 . . . . 0.0 116.526 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.92 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.22 -46.39 67.51 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.626 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.532 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.8 m170 -74.76 -25.74 59.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.447 1.118 . . . . 0.0 108.624 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.804 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.47 -30.59 71.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.087 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.97 -41.77 18.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.741 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.532 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -74.96 -17.0 60.62 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 112.232 -2.258 . . . . 0.0 110.237 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.98 -62.84 2.85 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.434 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.82 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 92.3 mt -98.79 8.19 45.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.6 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.863 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 7.16 -65.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 49.2 Cg_exo -59.55 -9.53 9.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.589 1.526 . . . . 0.0 111.745 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -59.34 -40.07 85.18 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.006 -2.361 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -89.0 -29.44 19.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.883 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.794 0.331 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.77 104.2 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.798 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 5' ' ' ASP . 7.1 p -178.79 128.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 111.223 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.91 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -114.24 11.98 17.58 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 122.204 1.002 . . . . 0.0 111.805 -179.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.451 ' H ' HG22 ' A' ' 3' ' ' VAL . 13.9 t70 -94.63 -14.14 25.22 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.649 ' HA ' ' NZ ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -74.3 -30.6 62.15 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.669 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.91 HG12 ' O ' ' A' ' 4' ' ' LYS . 8.9 p -57.19 -26.25 25.06 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.876 0 CA-C-N 111.07 -2.786 . . . . 0.0 111.908 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.649 ' NZ ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -46.64 -35.23 5.75 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.741 1.258 . . . . 0.0 109.491 -179.154 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -76.36 4.17 50.32 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.784 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.761 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 39.5 7.52 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 9' ' ' GLY . 68.8 m -94.59 -3.19 50.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.992 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.802 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 8.3 t70 -46.41 111.26 1.43 Allowed Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.409 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.876 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -69.17 -32.62 20.64 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 C-N-CA 123.555 2.836 . . . . 0.0 116.518 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.876 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.77 -46.2 66.34 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.52 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.566 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 58.0 m170 -74.64 -26.33 59.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.551 1.167 . . . . 0.0 108.463 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -62.07 -31.81 72.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.806 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -80.72 -42.02 22.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.595 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -72.04 -18.09 61.98 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.065 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.75 -62.5 3.18 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.373 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.29 56.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.704 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 95.2 mt -98.08 8.23 45.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.455 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.844 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.7 m 5.45 -64.26 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 51.1 Cg_exo -59.14 -9.74 8.82 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 121.672 1.581 . . . . 0.0 111.703 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.704 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -56.91 -24.39 51.9 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 111.955 -2.384 . . . . 0.0 111.279 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 10.6 mtmp? -51.14 -89.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.351 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.2 t0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.872 -179.928 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.859 0.362 . . . . 0.0 110.645 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.48 67.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.431 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 4' ' ' LYS . 8.7 p -122.52 -140.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.959 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -79.61 6.84 9.54 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.937 0.875 . . . . 0.0 112.02 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.408 ' OD1' ' HE3' ' A' ' 4' ' ' LYS . 1.6 m-20 -86.4 -11.84 50.83 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.532 ' O ' ' HD3' ' A' ' 8' ' ' LYS . 16.0 ttm-85 -73.89 -28.96 61.82 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.161 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.048 ' O ' ' N ' ' A' ' 10' ' ' LYS . 1.8 p -67.93 -28.36 41.04 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 111.032 -2.804 . . . . 0.0 110.904 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -8.38 -48.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.649 1.218 . . . . 0.0 111.874 -177.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -74.64 9.04 11.58 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.548 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 1.048 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 39.45 3.01 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 9' ' ' GLY . 41.2 t -95.5 -3.03 47.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.35 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.907 ' CB ' HG23 ' A' ' 7' ' ' VAL . 8.0 t70 -46.35 109.48 1.01 Allowed Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.268 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.955 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 44.2 Cg_endo -72.12 -34.01 8.75 Favored 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 123.597 2.865 . . . . 0.0 116.774 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.955 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -65.42 -46.72 78.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.481 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.641 ' O ' ' N ' ' A' ' 19' ' ' GLY . 3.6 m-70 -75.4 -25.2 57.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.398 1.094 . . . . 0.0 109.307 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -66.55 -27.77 68.0 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.805 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -88.94 -40.88 12.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.971 -178.162 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 77.2 p -82.04 -13.57 57.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.345 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -76.44 -62.9 2.46 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.193 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.17 60.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 85.5 mt -96.88 8.15 45.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.586 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.901 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 8.88 -66.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 45.9 Cg_exo -60.14 -8.47 8.28 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 122.004 1.803 . . . . 0.0 111.938 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -56.12 -40.09 73.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.725 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 22' ' ' SER . 45.7 pttt -56.28 -29.55 61.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 111.051 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.922 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.446 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.55 -151.24 15.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.409 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t 63.18 127.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 111.326 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.896 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -122.05 12.06 10.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 122.24 1.019 . . . . 0.0 111.621 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 53.4 m-20 -95.55 -11.55 27.19 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 113.662 -1.608 . . . . 0.0 106.662 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 16.3 ttm-85 -75.42 -36.48 60.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 112.94 -1.936 . . . . 0.0 109.392 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.013 ' O ' ' N ' ' A' ' 10' ' ' LYS . 8.6 p -70.51 -24.84 25.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.007 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.135 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -27.4 -42.11 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.254 1.026 . . . . 0.0 110.898 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.768 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -70.88 5.17 8.17 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.898 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 1.013 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 40.02 3.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.768 ' H ' ' C ' ' A' ' 9' ' ' GLY . 40.0 t -95.16 -0.88 52.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.729 ' CB ' HG23 ' A' ' 7' ' ' VAL . 6.3 t70 -46.17 109.54 1.01 Allowed Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.783 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.967 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 28.6 Cg_endo -70.61 -33.16 13.81 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 123.394 2.729 . . . . 0.0 116.54 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.967 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -64.89 -46.62 80.98 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.555 -178.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.696 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.4 m170 -74.9 -25.76 59.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.578 1.18 . . . . 0.0 109.343 176.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -69.17 -28.55 66.51 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.608 -2.087 . . . . 0.0 111.483 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.566 ' O ' HD12 ' A' ' 21' ' ' LEU . 1.2 m -98.35 -20.67 17.04 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.521 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.696 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -96.65 -15.87 21.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.686 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.15 -62.43 2.76 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.268 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 -25.07 58.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 79.6 mt -98.91 8.18 45.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.551 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.863 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.4 m 8.26 -65.76 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 43.0 Cg_exo -60.26 -9.24 10.07 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 121.53 1.487 . . . . 0.0 111.746 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -58.67 -40.21 82.89 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.282 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -85.35 -22.97 28.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.861 179.908 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HE3' ' H ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 122.314 1.054 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.74 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -69.0 0.8 12.68 Favored Glycine 0 C--N 1.299 -1.488 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.723 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 5.8 mmmm 46.94 -2.74 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.641 0.734 . . . . 0.0 112.937 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.74 ' H ' ' C ' ' A' ' 9' ' ' GLY . 39.0 t -93.94 -1.94 53.95 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.459 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.799 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.8 t70 -46.83 109.81 1.13 Allowed Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.924 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.935 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 34.1 Cg_endo -71.0 -33.13 12.33 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 123.586 2.857 . . . . 0.0 116.674 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.935 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.21 -46.13 71.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.615 -178.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.501 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.8 m170 -74.72 -26.0 59.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 108.649 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.799 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -64.07 -30.56 71.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.605 -2.088 . . . . 0.0 110.962 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.99 -41.72 20.34 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.832 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 87.7 p -74.32 -18.44 60.7 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 112.018 -2.355 . . . . 0.0 110.226 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -77.28 -59.16 3.17 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.435 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.78 -24.0 55.03 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.734 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 88.4 mt -102.26 7.44 40.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.659 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 57.2 m 16.52 -74.04 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.819 1.248 . . . . 0.0 114.313 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.659 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 15.8 Cg_endo -54.48 -15.28 8.46 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 C-N-CA 121.69 1.594 . . . . 0.0 112.31 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.844 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.014 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.494 -1.176 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -70.75 4.52 9.49 Favored Glycine 0 C--N 1.308 -1.01 0 CA-C-N 111.581 -2.554 . . . . 0.0 111.1 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 37.8 5.61 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 9' ' ' GLY . 45.5 t -94.93 -3.81 47.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.784 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 7.8 t70 -46.75 109.45 1.04 Allowed Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.941 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 37.3 Cg_endo -71.59 -33.48 10.56 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.576 2.85 . . . . 0.0 116.755 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.941 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -66.41 -47.06 74.45 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.045 -177.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.612 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 43.8 m170 -75.08 -25.81 58.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.502 1.144 . . . . 0.0 108.78 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.06 -30.54 71.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.019 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -84.16 -41.08 17.41 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.723 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 90.3 p -73.52 -18.7 61.06 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.193 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.09 -59.71 3.56 Favored Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.2 -24.95 57.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 88.4 mt -101.31 7.21 42.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.488 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.665 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 51.3 m 16.1 -74.47 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.682 1.193 . . . . 0.0 114.135 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.665 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.3 Cg_endo -54.88 -13.35 6.06 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.862 1.708 . . . . 0.0 112.54 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.792 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.081 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.495 -1.14 0 CA-C-O 122.844 1.307 . . . . 0.0 107.766 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.83 2.99 7.11 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.213 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 36.07 8.26 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.742 ' N ' ' O ' ' A' ' 9' ' ' GLY . 44.3 t -95.03 -8.78 35.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.186 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.826 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 11.8 t70 -47.1 108.09 0.82 Allowed Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.949 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 56.3 Cg_endo -73.51 -34.08 6.15 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 123.733 2.955 . . . . 0.0 117.368 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.949 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.97 -46.71 70.6 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.607 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 51.6 m170 -74.94 -25.71 59.08 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.462 1.125 . . . . 0.0 108.669 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.826 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.81 -32.38 72.67 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.715 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.0 -41.63 22.43 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.584 -178.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.607 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 91.9 p -70.09 -20.34 63.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.137 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -74.28 -59.37 3.92 Favored Glycine 0 CA--C 1.506 -0.502 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.328 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.6 -24.03 54.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.808 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 89.7 mt -101.52 7.33 42.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.425 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.677 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 45.1 m 16.34 -74.45 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.585 1.154 . . . . 0.0 113.989 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.677 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 22.3 Cg_endo -56.51 -9.98 4.45 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 121.857 1.705 . . . . 0.0 112.59 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.808 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.81 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.648 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 8' ' ' LYS . 7.6 mmmm . . . . . 0 CA--C 1.483 -1.609 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.19 0.83 10.21 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 110.392 -3.095 . . . . 0.0 111.074 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 38.17 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 9' ' ' GLY . 46.4 t -94.52 -9.7 34.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.508 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.802 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.1 t70 -46.93 109.85 1.14 Allowed Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.868 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.935 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 33.2 Cg_endo -71.0 -32.85 12.75 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 123.558 2.839 . . . . 0.0 116.813 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.935 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.54 -46.68 68.88 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.028 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.643 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.3 m170 -74.9 -25.78 59.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.565 1.174 . . . . 0.0 108.602 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.82 -31.82 72.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.646 -2.07 . . . . 0.0 110.654 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.89 -41.61 20.69 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.478 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.643 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -69.26 -20.37 63.93 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.893 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.22 -58.22 4.78 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.145 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.83 59.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.79 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 89.9 mt -100.25 7.19 44.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.349 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.665 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 49.8 m 15.35 -73.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.702 1.201 . . . . 0.0 114.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.665 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.7 Cg_endo -54.88 -13.74 6.75 Favored 'Trans proline' 0 CA--C 1.508 -0.793 0 C-N-CA 121.787 1.658 . . . . 0.0 112.385 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.79 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.847 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.87 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.562 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.654 0 CA-C-O 121.574 0.702 . . . . 0.0 111.948 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.77 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -75.55 8.3 20.67 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.418 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt 46.6 -4.88 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.77 ' H ' ' C ' ' A' ' 9' ' ' GLY . 35.8 t -94.66 -1.04 53.86 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.491 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.839 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 7.2 t70 -46.4 111.53 1.52 Allowed Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.27 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.863 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 24.1 Cg_endo -69.06 -30.56 25.34 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 123.732 2.955 . . . . 0.0 116.693 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.863 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -73.06 -46.11 53.54 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.35 -178.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.592 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 61.0 m170 -74.46 -25.58 59.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.495 1.141 . . . . 0.0 108.365 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.97 -32.42 72.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.577 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -79.96 -41.93 24.99 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.559 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 82.5 p -70.98 -19.52 62.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.175 -2.284 . . . . 0.0 109.975 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.11 -57.51 4.34 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -24.6 58.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 91.3 mt -100.3 7.27 44.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.382 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.685 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 44.8 m 15.89 -74.32 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.59 1.156 . . . . 0.0 113.814 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.685 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 20.3 Cg_endo -55.77 -9.76 3.23 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 121.957 1.771 . . . . 0.0 112.553 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.294 -1.806 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.431 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.566 ' O ' ' HD2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.286 0 CA-C-O 122.933 1.349 . . . . 0.0 107.366 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.744 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -67.69 1.86 7.0 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 111.546 -2.57 . . . . 0.0 111.252 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 37.3 8.32 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.744 ' N ' ' O ' ' A' ' 9' ' ' GLY . 47.0 t -94.59 -6.02 44.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.37 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.793 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 13.2 t70 -46.81 109.3 1.01 Allowed Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.205 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.946 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 46.9 Cg_endo -72.1 -33.56 9.35 Favored 'Trans proline' 0 C--N 1.327 -0.564 0 C-N-CA 123.614 2.876 . . . . 0.0 116.622 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.946 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.29 -46.42 73.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.787 -177.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.56 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 55.8 m170 -74.92 -25.8 59.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.517 1.151 . . . . 0.0 108.765 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.793 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.37 -30.82 71.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.025 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 -41.8 18.67 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.66 -1.609 . . . . 0.0 108.694 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.7 p -73.89 -17.27 61.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.157 -2.292 . . . . 0.0 110.054 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.84 -63.07 2.96 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.33 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.43 -24.97 58.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.726 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 93.9 mt -97.63 8.23 45.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.496 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.832 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.1 m 5.59 -64.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.832 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 48.6 Cg_exo -59.6 -9.72 9.8 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 121.541 1.494 . . . . 0.0 111.772 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 111.976 -2.374 . . . . 0.0 111.15 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.929 0 CA-C-O 122.215 1.007 . . . . 0.0 110.685 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.741 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -68.29 2.56 7.04 Favored Glycine 0 C--N 1.3 -1.446 0 CA-C-N 113.23 -1.805 . . . . 0.0 110.816 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 8' ' ' LYS . 4.2 mmtt 45.78 -2.54 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 113.057 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.741 ' H ' ' C ' ' A' ' 9' ' ' GLY . 69.2 m -94.02 -1.35 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.473 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.804 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.2 t70 -46.89 110.47 1.28 Allowed Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.805 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.92 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 20.3 Cg_endo -69.64 -32.72 18.5 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 123.516 2.811 . . . . 0.0 116.526 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.92 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.22 -46.39 67.51 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.626 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.532 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.8 m170 -74.76 -25.74 59.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.447 1.118 . . . . 0.0 108.624 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.804 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.47 -30.59 71.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.087 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.97 -41.77 18.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.741 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.532 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -74.96 -17.0 60.62 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 112.232 -2.258 . . . . 0.0 110.237 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.98 -62.84 2.85 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.434 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.82 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 92.3 mt -98.79 8.19 45.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.6 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.863 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 7.16 -65.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 49.2 Cg_exo -59.55 -9.53 9.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.589 1.526 . . . . 0.0 111.745 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.04 0 CA-C-N 112.006 -2.361 . . . . 0.0 111.112 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.563 ' HE3' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.902 0 CA-C-O 122.741 1.258 . . . . 0.0 109.491 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -76.36 4.17 50.32 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.784 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.438 ' CD ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 39.5 7.52 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 9' ' ' GLY . 68.8 m -94.59 -3.19 50.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.992 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.798 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 8.3 t70 -46.41 111.26 1.43 Allowed Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.409 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.876 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -69.17 -32.62 20.64 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 C-N-CA 123.555 2.836 . . . . 0.0 116.518 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.876 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.77 -46.2 66.34 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.52 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.566 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 58.0 m170 -74.64 -26.33 59.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.551 1.167 . . . . 0.0 108.463 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -62.07 -31.81 72.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.806 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -80.72 -42.02 22.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.595 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -72.04 -18.09 61.98 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.065 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.75 -62.5 3.18 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.373 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.29 56.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.704 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 95.2 mt -98.08 8.23 45.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.455 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.844 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.7 m 5.45 -64.26 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 51.1 Cg_exo -59.14 -9.74 8.82 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 121.672 1.581 . . . . 0.0 111.703 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.704 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.046 0 CA-C-N 111.955 -2.384 . . . . 0.0 111.279 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.757 0 CA-C-O 121.803 0.811 . . . . 0.0 111.874 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.764 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -74.64 9.04 11.58 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.548 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.441 ' CD ' ' C ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER 39.45 3.01 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 9' ' ' GLY . 41.2 t -95.5 -3.03 47.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.35 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.789 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 8.0 t70 -46.35 109.48 1.01 Allowed Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.268 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.955 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 44.2 Cg_endo -72.12 -34.01 8.75 Favored 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 123.597 2.865 . . . . 0.0 116.774 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.955 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -65.42 -46.72 78.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.481 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.641 ' O ' ' N ' ' A' ' 19' ' ' GLY . 57.5 m170 -75.4 -25.2 57.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.398 1.094 . . . . 0.0 109.307 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -66.55 -27.77 68.0 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.805 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -88.94 -40.88 12.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.971 -178.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 77.2 p -82.04 -13.57 57.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.345 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -76.44 -62.9 2.46 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.193 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.17 60.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 85.5 mt -96.88 8.15 45.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.586 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.901 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 8.88 -66.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 45.9 Cg_exo -60.14 -8.47 8.28 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 122.004 1.803 . . . . 0.0 111.938 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.059 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.725 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.501 -0.93 0 CA-C-O 122.254 1.026 . . . . 0.0 110.898 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.768 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -70.88 5.17 8.17 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.898 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 40.02 3.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.768 ' H ' ' C ' ' A' ' 9' ' ' GLY . 40.0 t -95.16 -0.88 52.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.721 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.3 t70 -46.17 109.54 1.01 Allowed Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.783 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.967 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 28.6 Cg_endo -70.61 -33.16 13.81 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 123.394 2.729 . . . . 0.0 116.54 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.967 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -64.89 -46.62 80.98 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.555 -178.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.696 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.4 m170 -74.9 -25.76 59.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.578 1.18 . . . . 0.0 109.343 176.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -69.17 -28.55 66.51 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.608 -2.087 . . . . 0.0 111.483 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.566 ' O ' HD12 ' A' ' 21' ' ' LEU . 1.2 m -98.35 -20.67 17.04 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.521 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.696 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -96.65 -15.87 21.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.686 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.15 -62.43 2.76 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.268 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 -25.07 58.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 79.6 mt -98.91 8.18 45.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.551 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.863 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.4 m 8.26 -65.76 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 43.0 Cg_exo -60.26 -9.24 10.07 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 121.53 1.487 . . . . 0.0 111.746 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . . . . . . 0 C--N 1.289 -2.061 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.282 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.499 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.22 146.97 18.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.433 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 p 177.52 138.25 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 CA-C-O 121.881 0.848 . . . . 0.0 111.019 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.894 ' C ' ' H ' ' A' ' 6' ' ' ARG . 5.4 ptmm? -126.78 -109.41 0.3 Allowed 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.133 -1.394 . . . . 0.0 107.376 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 36.4 t70 61.99 -37.71 0.13 Allowed 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 122.956 1.36 . . . . 0.0 108.549 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.894 ' H ' ' C ' ' A' ' 4' ' ' LYS . 8.1 ttm105 -73.74 -33.8 64.48 Favored 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 112.216 -2.265 . . . . 0.0 110.355 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.974 ' O ' ' N ' ' A' ' 10' ' ' LYS . 4.5 p -69.27 -24.72 28.12 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.982 0 CA-C-N 111.039 -2.801 . . . . 0.0 111.286 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.523 ' HE3' ' H ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -31.44 -39.84 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 122.314 1.054 . . . . 0.0 110.844 -177.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.74 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -69.0 0.8 12.68 Favored Glycine 0 C--N 1.299 -1.488 0 CA-C-N 113.132 -1.849 . . . . 0.0 110.723 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.974 ' N ' ' O ' ' A' ' 7' ' ' VAL . 5.8 mmmm 46.94 -2.74 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.641 0.734 . . . . 0.0 112.937 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.74 ' H ' ' C ' ' A' ' 9' ' ' GLY . 39.0 t -93.94 -1.94 53.95 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.459 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.799 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 6.8 t70 -46.83 109.81 1.13 Allowed Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.924 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.935 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 34.1 Cg_endo -71.0 -33.13 12.33 Favored 'Trans proline' 0 C--N 1.329 -0.462 0 C-N-CA 123.586 2.857 . . . . 0.0 116.674 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.935 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.21 -46.13 71.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.615 -178.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.501 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.8 m170 -74.72 -26.0 59.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.603 1.192 . . . . 0.0 108.649 176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.799 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -64.07 -30.56 71.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.605 -2.088 . . . . 0.0 110.962 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.99 -41.72 20.34 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.832 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 87.7 p -74.32 -18.44 60.7 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 112.018 -2.355 . . . . 0.0 110.226 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -77.28 -59.16 3.17 Favored Glycine 0 CA--C 1.505 -0.577 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.435 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.78 -24.0 55.03 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.734 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 88.4 mt -102.26 7.44 40.72 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.287 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.659 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 57.2 m 16.52 -74.04 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 124.819 1.248 . . . . 0.0 114.313 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.659 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 15.8 Cg_endo -54.48 -15.28 8.46 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 C-N-CA 121.69 1.594 . . . . 0.0 112.31 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -63.98 -30.37 71.45 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 112.971 -1.922 . . . . 0.0 111.014 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.0 -89.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.203 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.875 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.782 0.325 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.64 105.12 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.685 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -158.39 121.26 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.153 0.502 . . . . 0.0 110.694 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.25 28.44 5.25 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 122.51 1.148 . . . . 0.0 111.745 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 1.5 m-20 -100.34 -18.63 16.69 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 112.996 -1.911 . . . . 0.0 106.963 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -75.42 -33.7 60.95 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 113.048 -1.887 . . . . 0.0 110.965 177.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 4' ' ' LYS . 20.9 m -54.67 -26.9 17.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 110.932 -2.849 . . . . 0.0 110.248 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -50.44 -39.75 48.53 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -70.75 4.52 9.49 Favored Glycine 0 C--N 1.308 -1.01 0 CA-C-N 111.581 -2.554 . . . . 0.0 111.1 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.685 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 37.8 5.61 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 9' ' ' GLY . 45.5 t -94.93 -3.81 47.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.784 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 7.8 t70 -46.75 109.45 1.04 Allowed Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.941 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 37.3 Cg_endo -71.59 -33.48 10.56 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.576 2.85 . . . . 0.0 116.755 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.941 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -66.41 -47.06 74.45 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.045 -177.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.612 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 43.8 m170 -75.08 -25.81 58.85 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 122.502 1.144 . . . . 0.0 108.78 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.06 -30.54 71.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 112.747 -2.024 . . . . 0.0 111.019 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -84.16 -41.08 17.41 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.72 -1.582 . . . . 0.0 108.723 -178.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 90.3 p -73.52 -18.7 61.06 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.193 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.09 -59.71 3.56 Favored Glycine 0 CA--C 1.504 -0.603 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.284 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.2 -24.95 57.96 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 88.4 mt -101.31 7.21 42.92 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.488 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.665 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 51.3 m 16.1 -74.47 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.682 1.193 . . . . 0.0 114.135 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.665 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.3 Cg_endo -54.88 -13.35 6.06 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.862 1.708 . . . . 0.0 112.54 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.784 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -57.28 -31.53 65.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.081 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -105.41 -40.86 5.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.186 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.919 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.944 0.402 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.14 -74.59 0.52 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.511 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.581 HG22 ' H ' ' A' ' 5' ' ' ASP . 7.1 p 179.6 130.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.548 . . . . 0.0 111.003 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.518 ' C ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -122.33 29.19 7.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.605 1.193 . . . . 0.0 111.303 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.644 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 67.4 m-20 -103.89 -14.89 15.83 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 112.639 -2.073 . . . . 0.0 107.386 176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.61 ' HD3' ' CE1' ' A' ' 14' ' ' TYR . 2.3 ttm105 -76.14 -42.64 46.17 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 113.053 -1.885 . . . . 0.0 109.94 177.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.754 ' O ' ' N ' ' A' ' 10' ' ' LYS . 3.4 m -56.23 -25.39 19.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 CA-C-N 109.959 -3.291 . . . . 0.0 110.544 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HB3' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -46.73 -41.52 15.29 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.844 1.307 . . . . 0.0 107.766 177.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.742 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.83 2.99 7.11 Favored Glycine 0 C--N 1.307 -1.059 0 CA-C-N 111.953 -2.385 . . . . 0.0 111.213 177.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 36.07 8.26 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.742 ' N ' ' O ' ' A' ' 9' ' ' GLY . 44.3 t -95.03 -8.78 35.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.186 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.826 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 11.8 t70 -47.1 108.09 0.82 Allowed Pre-proline 0 C--N 1.312 -1.048 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.104 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.949 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 56.3 Cg_endo -73.51 -34.08 6.15 Favored 'Trans proline' 0 C--N 1.33 -0.413 0 C-N-CA 123.733 2.955 . . . . 0.0 117.368 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.949 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.97 -46.71 70.6 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.116 -177.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.607 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 51.6 m170 -74.94 -25.71 59.08 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 122.462 1.125 . . . . 0.0 108.669 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.826 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.81 -32.38 72.67 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.715 178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.0 -41.63 22.43 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 113.475 -1.693 . . . . 0.0 108.584 -178.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.607 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 91.9 p -70.09 -20.34 63.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 112.144 -2.298 . . . . 0.0 110.137 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -74.28 -59.37 3.92 Favored Glycine 0 CA--C 1.506 -0.502 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.328 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.6 -24.03 54.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.808 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 89.7 mt -101.52 7.33 42.4 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.425 179.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.677 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 45.1 m 16.34 -74.45 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.585 1.154 . . . . 0.0 113.989 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.677 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 22.3 Cg_endo -56.51 -9.98 4.45 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 C-N-CA 121.857 1.705 . . . . 0.0 112.59 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.808 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -56.64 -40.18 74.98 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.147 -1.842 . . . . 0.0 111.648 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 22' ' ' SER . 18.6 pttp -71.59 -39.11 70.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.957 179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 pttp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.805 0.336 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 3' ' ' VAL . . . -121.76 -34.32 0.86 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.821 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 2' ' ' GLY . 3.7 p 46.12 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.729 0.776 . . . . 0.0 112.255 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.603 ' C ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -128.24 28.56 5.48 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.449 1.119 . . . . 0.0 112.038 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.574 ' C ' ' HG2' ' A' ' 8' ' ' LYS . 59.1 p30 -99.74 -18.12 17.39 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 113.071 -1.877 . . . . 0.0 107.458 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.496 ' HD2' ' OD1' ' A' ' 12' ' ' ASP . 24.7 ttm-85 -76.97 -41.2 44.06 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-N 111.904 -2.407 . . . . 0.0 111.206 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.917 HG23 ' HD2' ' A' ' 8' ' ' LYS . 16.1 m -57.76 -27.92 31.44 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-N 110.693 -2.958 . . . . 0.0 110.806 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.917 ' HD2' HG23 ' A' ' 7' ' ' VAL . 7.6 mmmm -63.86 -34.8 78.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 177.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -68.19 0.83 10.21 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 110.392 -3.095 . . . . 0.0 111.074 176.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 38.17 9.42 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.7 ' N ' ' O ' ' A' ' 9' ' ' GLY . 46.4 t -94.52 -9.7 34.49 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.508 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.802 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 10.1 t70 -46.93 109.85 1.14 Allowed Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.868 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.935 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 33.2 Cg_endo -71.0 -32.85 12.75 Favored 'Trans proline' 0 C--N 1.327 -0.56 0 C-N-CA 123.558 2.839 . . . . 0.0 116.813 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.935 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -68.54 -46.68 68.88 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.028 -177.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.643 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 54.3 m170 -74.9 -25.78 59.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 122.565 1.174 . . . . 0.0 108.602 176.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.82 -31.82 72.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 112.646 -2.07 . . . . 0.0 110.654 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.665 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -81.89 -41.61 20.69 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 113.541 -1.663 . . . . 0.0 108.478 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.643 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -69.26 -20.37 63.93 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.893 177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.22 -58.22 4.78 Favored Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.145 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.83 59.15 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.79 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 89.9 mt -100.25 7.19 44.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.349 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.665 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 49.8 m 15.35 -73.81 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.702 1.201 . . . . 0.0 114.219 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.665 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 19.7 Cg_endo -54.88 -13.74 6.75 Favored 'Trans proline' 0 CA--C 1.508 -0.793 0 C-N-CA 121.787 1.658 . . . . 0.0 112.385 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.79 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -58.78 -35.72 73.25 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 113.154 -1.839 . . . . 0.0 110.87 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -99.58 -40.55 7.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.032 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.4 t0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.885 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.754 0.311 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.94 96.83 0.41 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.78 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.427 ' O ' ' CE1' ' A' ' 15' ' ' HIS . 42.4 t -157.7 119.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.144 0.497 . . . . 0.0 110.792 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.905 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -136.67 21.98 3.11 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.318 1.056 . . . . 0.0 111.296 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -95.35 -13.75 24.47 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 113.321 -1.763 . . . . 0.0 107.105 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.643 ' O ' ' HD3' ' A' ' 8' ' ' LYS . 7.3 ttt85 -74.37 -31.68 62.47 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.144 -1.844 . . . . 0.0 109.28 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.964 ' O ' ' N ' ' A' ' 9' ' ' GLY . 2.8 p -67.59 -29.28 44.84 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 110.858 -2.883 . . . . 0.0 110.558 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.643 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 4.25 -51.17 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 O-C-N 124.924 1.39 . . . . 0.0 111.948 -177.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.964 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -75.55 8.3 20.67 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.418 176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.887 ' N ' ' O ' ' A' ' 7' ' ' VAL . 20.3 mmmt 46.6 -4.88 0.0 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.77 ' H ' ' C ' ' A' ' 9' ' ' GLY . 35.8 t -94.66 -1.04 53.86 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.491 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.931 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 7.2 t70 -46.4 111.53 1.52 Allowed Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.27 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.863 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 24.1 Cg_endo -69.06 -30.56 25.34 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 123.732 2.955 . . . . 0.0 116.693 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.863 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -73.06 -46.11 53.54 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.35 -178.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.592 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 61.0 m170 -74.46 -25.58 59.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.495 1.141 . . . . 0.0 108.365 176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.839 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -61.97 -32.42 72.86 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 112.634 -2.076 . . . . 0.0 110.577 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.658 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -79.96 -41.93 24.99 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.559 -178.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.592 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 82.5 p -70.98 -19.52 62.53 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.175 -2.284 . . . . 0.0 109.975 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.11 -57.51 4.34 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.0 -24.6 58.88 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 91.3 mt -100.3 7.27 44.49 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.382 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.685 ' HB2' ' CD ' ' A' ' 23' ' ' PRO . 44.8 m 15.89 -74.32 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.59 1.156 . . . . 0.0 113.814 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.685 ' CD ' ' HB2' ' A' ' 22' ' ' SER . 20.3 Cg_endo -55.77 -9.76 3.23 Favored 'Trans proline' 0 CA--C 1.51 -0.681 0 C-N-CA 121.957 1.771 . . . . 0.0 112.553 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -56.35 -38.23 71.1 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 113.161 -1.836 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -59.68 -31.79 69.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.818 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.045 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.5 tptt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.885 0.374 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.42 -179.08 48.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.606 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.3 t -159.09 123.07 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 0.0 110.775 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.802 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -124.89 27.12 6.86 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.788 1.28 . . . . 0.0 111.433 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.567 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 8.1 m-20 -97.18 -21.2 17.45 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 112.482 -2.144 . . . . 0.0 107.301 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.19 -36.19 61.45 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-N 112.452 -2.158 . . . . 0.0 111.025 179.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 4' ' ' LYS . 13.2 m -55.65 -27.39 21.56 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.729 0 CA-C-N 110.607 -2.997 . . . . 0.0 110.215 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -51.42 -39.64 57.7 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.933 1.349 . . . . 0.0 107.366 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.744 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -67.69 1.86 7.0 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 111.546 -2.57 . . . . 0.0 111.252 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 37.3 8.32 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.744 ' N ' ' O ' ' A' ' 9' ' ' GLY . 47.0 t -94.59 -6.02 44.5 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.37 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.793 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 13.2 t70 -46.81 109.3 1.01 Allowed Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.205 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.946 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 46.9 Cg_endo -72.1 -33.56 9.35 Favored 'Trans proline' 0 C--N 1.327 -0.564 0 C-N-CA 123.614 2.876 . . . . 0.0 116.622 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.946 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -67.29 -46.42 73.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.787 -177.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.56 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 55.8 m170 -74.92 -25.8 59.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.517 1.151 . . . . 0.0 108.765 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.793 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.37 -30.82 71.88 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 112.781 -2.009 . . . . 0.0 111.025 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.8 -41.8 18.67 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 113.66 -1.609 . . . . 0.0 108.694 -178.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.7 p -73.89 -17.27 61.06 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.157 -2.292 . . . . 0.0 110.054 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.84 -63.07 2.96 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.33 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.43 -24.97 58.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.726 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 93.9 mt -97.63 8.23 45.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.496 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.832 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.1 m 5.59 -64.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.832 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 48.6 Cg_exo -59.6 -9.72 9.8 Favored 'Trans proline' 0 CA--C 1.504 -0.978 0 C-N-CA 121.541 1.494 . . . . 0.0 111.772 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.726 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -57.14 -36.78 71.12 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 111.976 -2.374 . . . . 0.0 111.15 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 10.7 mtmp? -60.46 -88.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.989 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.9 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.842 0.354 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.29 -171.55 21.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.65 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.859 HG22 ' H ' ' A' ' 5' ' ' ASP . 11.4 p 175.94 136.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 121.005 0.431 . . . . 0.0 110.279 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.869 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -102.37 18.13 21.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.23 1.014 . . . . 0.0 112.074 -179.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.859 ' H ' HG22 ' A' ' 3' ' ' VAL . 51.1 m-20 -99.99 -12.06 20.08 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 113.464 -1.698 . . . . 0.0 106.486 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.541 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 17.2 ttm180 -74.97 -34.45 62.03 Favored 'General case' 0 CA--C 1.48 -1.726 0 CA-C-N 112.711 -2.041 . . . . 0.0 109.572 177.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.956 ' O ' ' N ' ' A' ' 10' ' ' LYS . 8.1 p -67.54 -25.1 32.33 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.061 0 CA-C-N 110.296 -3.138 . . . . 0.0 111.34 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.541 ' CE ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -30.57 -39.97 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 122.215 1.007 . . . . 0.0 110.685 -177.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.741 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -68.29 2.56 7.04 Favored Glycine 0 C--N 1.3 -1.446 0 CA-C-N 113.23 -1.805 . . . . 0.0 110.816 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.956 ' N ' ' O ' ' A' ' 7' ' ' VAL . 4.2 mmtt 45.78 -2.54 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 113.057 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.741 ' H ' ' C ' ' A' ' 9' ' ' GLY . 69.2 m -94.02 -1.35 54.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.473 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.842 ' CB ' HG23 ' A' ' 7' ' ' VAL . 6.2 t70 -46.89 110.47 1.28 Allowed Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.805 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.92 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 20.3 Cg_endo -69.64 -32.72 18.5 Favored 'Trans proline' 0 C--N 1.327 -0.571 0 C-N-CA 123.516 2.811 . . . . 0.0 116.526 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.92 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.22 -46.39 67.51 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.626 -178.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.532 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.8 m170 -74.76 -25.74 59.29 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.447 1.118 . . . . 0.0 108.624 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.804 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -63.47 -30.59 71.69 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.087 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -82.97 -41.77 18.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 113.664 -1.607 . . . . 0.0 108.741 -178.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.532 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -74.96 -17.0 60.62 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 112.232 -2.258 . . . . 0.0 110.237 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -73.98 -62.84 2.85 Favored Glycine 0 CA--C 1.504 -0.621 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.434 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.82 57.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 92.3 mt -98.79 8.19 45.23 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.384 -1.28 . . . . 0.0 111.6 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.863 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 7.16 -65.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 49.2 Cg_exo -59.55 -9.53 9.25 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.589 1.526 . . . . 0.0 111.745 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -59.34 -40.07 85.18 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 112.006 -2.361 . . . . 0.0 111.112 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -89.0 -29.44 19.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.094 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.883 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.794 0.331 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.77 104.2 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.798 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 5' ' ' ASP . 7.1 p -178.79 128.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.253 0.549 . . . . 0.0 111.223 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.91 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -114.24 11.98 17.58 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 122.204 1.002 . . . . 0.0 111.805 -179.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.451 ' H ' HG22 ' A' ' 3' ' ' VAL . 13.9 t70 -94.63 -14.14 25.22 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.649 ' HA ' ' NZ ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -74.3 -30.6 62.15 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 112.031 -2.35 . . . . 0.0 110.669 178.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.91 HG12 ' O ' ' A' ' 4' ' ' LYS . 8.9 p -57.19 -26.25 25.06 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.876 0 CA-C-N 111.07 -2.786 . . . . 0.0 111.908 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.649 ' NZ ' ' HA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -46.64 -35.23 5.75 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.741 1.258 . . . . 0.0 109.491 -179.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -76.36 4.17 50.32 Favored Glycine 0 C--N 1.298 -1.567 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.784 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.761 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 39.5 7.52 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.705 ' N ' ' O ' ' A' ' 9' ' ' GLY . 68.8 m -94.59 -3.19 50.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.992 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.802 ' HB2' ' HA ' ' A' ' 7' ' ' VAL . 8.3 t70 -46.41 111.26 1.43 Allowed Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 114.22 -1.355 . . . . 0.0 110.409 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.876 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 19.4 Cg_endo -69.17 -32.62 20.64 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 C-N-CA 123.555 2.836 . . . . 0.0 116.518 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.876 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -69.77 -46.2 66.34 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.52 -178.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.566 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 58.0 m170 -74.64 -26.33 59.8 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.551 1.167 . . . . 0.0 108.463 176.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -62.07 -31.81 72.27 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 112.598 -2.092 . . . . 0.0 110.806 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -80.72 -42.02 22.63 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 113.48 -1.691 . . . . 0.0 108.595 -178.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 85.4 p -72.04 -18.09 61.98 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.065 177.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -72.75 -62.5 3.18 Favored Glycine 0 CA--C 1.504 -0.597 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.373 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.8 -24.29 56.53 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.704 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 95.2 mt -98.08 8.23 45.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.455 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.844 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 48.7 m 5.45 -64.26 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 51.1 Cg_exo -59.14 -9.74 8.82 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 121.672 1.581 . . . . 0.0 111.703 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.704 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -56.91 -24.39 51.9 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 111.955 -2.384 . . . . 0.0 111.279 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.477 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 10.6 mtmp? -51.14 -89.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.351 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 65.2 t0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.872 -179.928 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.859 0.362 . . . . 0.0 110.645 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.48 67.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.431 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG22 ' H ' ' A' ' 4' ' ' LYS . 8.7 p -122.52 -140.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.959 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -79.61 6.84 9.54 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.937 0.875 . . . . 0.0 112.02 -179.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.408 ' OD1' ' HE3' ' A' ' 4' ' ' LYS . 1.6 m-20 -86.4 -11.84 50.83 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.532 ' O ' ' HD3' ' A' ' 8' ' ' LYS . 16.0 ttm-85 -73.89 -28.96 61.82 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.161 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.048 ' O ' ' N ' ' A' ' 10' ' ' LYS . 1.8 p -67.93 -28.36 41.04 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 111.032 -2.804 . . . . 0.0 110.904 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -8.38 -48.05 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.649 1.218 . . . . 0.0 111.874 -177.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 7' ' ' VAL . . . -74.64 9.04 11.58 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.548 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 1.048 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 39.45 3.01 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.764 ' N ' ' O ' ' A' ' 9' ' ' GLY . 41.2 t -95.5 -3.03 47.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.35 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.907 ' CB ' HG23 ' A' ' 7' ' ' VAL . 8.0 t70 -46.35 109.48 1.01 Allowed Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.268 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.955 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 44.2 Cg_endo -72.12 -34.01 8.75 Favored 'Trans proline' 0 C--N 1.33 -0.425 0 C-N-CA 123.597 2.865 . . . . 0.0 116.774 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.955 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -65.42 -46.72 78.85 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.481 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.641 ' O ' ' N ' ' A' ' 19' ' ' GLY . 57.5 m170 -75.4 -25.2 57.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.398 1.094 . . . . 0.0 109.307 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.789 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -66.55 -27.77 68.0 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.805 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -88.94 -40.88 12.74 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.971 -178.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 77.2 p -82.04 -13.57 57.15 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.345 177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -76.44 -62.9 2.46 Favored Glycine 0 CA--C 1.502 -0.769 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.193 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.17 60.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 85.5 mt -96.88 8.15 45.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.352 -1.295 . . . . 0.0 111.586 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.901 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 49.6 m 8.88 -66.94 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.901 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 45.9 Cg_exo -60.14 -8.47 8.28 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 122.004 1.803 . . . . 0.0 111.938 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.743 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -56.12 -40.09 73.2 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 112.136 -2.302 . . . . 0.0 111.725 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 22' ' ' SER . 45.7 pttt -56.28 -29.55 61.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.831 0.348 . . . . 0.0 111.051 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.922 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.446 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.879 0.371 . . . . 0.0 111.183 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.55 -151.24 15.77 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.409 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t 63.18 127.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.142 0.496 . . . . 0.0 111.326 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.896 ' O ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -122.05 12.06 10.33 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 122.24 1.019 . . . . 0.0 111.621 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 8' ' ' LYS . 53.4 m-20 -95.55 -11.55 27.19 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 113.662 -1.608 . . . . 0.0 106.662 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' O ' ' CE ' ' A' ' 8' ' ' LYS . 16.3 ttm-85 -75.42 -36.48 60.79 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 112.94 -1.936 . . . . 0.0 109.392 177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.013 ' O ' ' N ' ' A' ' 10' ' ' LYS . 8.6 p -70.51 -24.84 25.84 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.007 0 CA-C-N 110.204 -3.18 . . . . 0.0 111.135 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.599 ' HG2' ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -27.4 -42.11 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.254 1.026 . . . . 0.0 110.898 -177.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.768 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -70.88 5.17 8.17 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.898 177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 1.013 ' N ' ' O ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 40.02 3.13 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.768 ' H ' ' C ' ' A' ' 9' ' ' GLY . 40.0 t -95.16 -0.88 52.86 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.695 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.729 ' CB ' HG23 ' A' ' 7' ' ' VAL . 6.3 t70 -46.17 109.54 1.01 Allowed Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.783 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.967 ' HD2' ' CE1' ' A' ' 14' ' ' TYR . 28.6 Cg_endo -70.61 -33.16 13.81 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 123.394 2.729 . . . . 0.0 116.54 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.967 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -64.89 -46.62 80.98 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.555 -178.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.696 ' HA ' ' OG ' ' A' ' 18' ' ' SER . 57.4 m170 -74.9 -25.76 59.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 122.578 1.18 . . . . 0.0 109.343 176.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 12' ' ' ASP . . . -69.17 -28.55 66.51 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 112.608 -2.087 . . . . 0.0 111.483 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.566 ' O ' HD12 ' A' ' 21' ' ' LEU . 1.2 m -98.35 -20.67 17.04 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.521 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.696 ' OG ' ' HA ' ' A' ' 15' ' ' HIS . 88.0 p -96.65 -15.87 21.27 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.103 -1.862 . . . . 0.0 109.686 176.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 15' ' ' HIS . . . -75.15 -62.43 2.76 Favored Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.268 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.4 -25.07 58.99 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 24' ' ' ALA . 79.6 mt -98.91 8.18 45.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.551 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.863 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 50.4 m 8.26 -65.76 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.863 ' HD3' ' HB2' ' A' ' 22' ' ' SER . 43.0 Cg_exo -60.26 -9.24 10.07 Favored 'Trans proline' 0 CA--C 1.506 -0.887 0 C-N-CA 121.53 1.487 . . . . 0.0 111.746 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . . . -58.67 -40.21 82.89 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.282 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.532 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -85.35 -22.97 28.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.15 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.861 179.908 . . . . . . . . 0 0 . 1 stop_ save_